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IMPACT OF TIMING OF PROTEIN INTAKE ON NITROGEN BALANCE IN 
EXERCISING OLDER INDIVIDUALS ON HYPERCALORIC DIET 
 
 We have previously shown that in older adults, consumption of protein in the 
form of chocolate milk immediately after exercise enhances nitrogen balance (NBAL) 
when energy balance is maintained.  Since it is known that hypercaloric diets increase 
nitrogen (N) retention, it is important to know if the timing of protein intake after aerobic 
exercise provides further increases in N retention compared to the consumption of 
carbohydrate only post exercise.  PURPOSE:  To investigate if consumption of protein 
and carbohydrate (PRO + CHO) immediately after exercise as opposed to earlier in the 
day can improve NBAL in older individuals consuming a hypercaloric diet.  
METHODS: In a randomized cross-over design, subjects completed two separate 3-day 
exercise and nutrition interventions.  Exercise (60 minutes of stationary cycling at 55% of 
VO2max) was performed daily at 4:30 PM.  Diets were hypercaloric (calculated at +15% 
daily intake), with a PRO+CHO or carbohydrate only (CHO) drink consumed at 10 am 
and the opposite drink consumed after exercise (5:30 PM).  Both diets (1.2 g protein/kg 
bodyweight, 30% fat, and balance as carbohydrate) were isonitrogenous and isocaloric 
with only the timing of the drinks differing.  A 24 hour stay in a metabolic chamber 
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confirmed positive energy balance while 24-hour urine collections determined NBAL. 
RESULTS: The 3-day mean NBAL was not significantly different (p=.0881) (n=6) 
between the CHO trial (.970 ± .517 g N) and the PRO + CHO trial (1.659 ± .430 g N) 
although a trend toward increased NBAL with PRO+CHO was apparent.  The mean 
energy balance was not significantly different (p=.2906) between the CHO trial (+13.09 ± 
1.94%) and the PRO + CHO trial (+ 14.28 ± 1.75%).  Further analyses comparing the 
positive energy balance cohort to previously completed negative, and even energy 
balance cohorts distinguished the role of energy balance and timing of nutrition effects.  
CONCLUSION: Older individuals in positive energy balance do not maintain a 
significantly more positive NBAL balance by consuming protein after aerobic exercise as 
opposed to earlier in the day although energy balance does change the effect of protein 
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Sarcopenia is a prevalent condition as individuals age, described by a decrease in muscle 
mass, strength, and fatigue resistance (Jackman RW 2004).  Sarcopenia is observed in 50% of 
individuals over the age of 80, and 13-24% or individuals under age 70 (Baumgartner RN 1998), 
with muscle cross sectional area (CSA) declining by approximately 40% from the age of 20 to 80 
(Berger MJ 2010).  With declines in muscle size, come declines in muscle strength (Fiatarone, 
Marks et al. 1990; Frontera, Hughes et al. 1991).  Elderly populations in their seventh and eighth 
decade have an average strength decline of 20-40% in their knee extensors compared to their  
younger counterparts, with relative strength losses observed for muscles of both the upper and 
lower extremities (Berger MJ 2010).   Age related decreases in muscle CSA and strength lead to 
an overall decrease in muscle quality (MQ), which refers to strength per unit of muscle mass.  
When corrected for a decline in absolute muscle mass, the amount of peak torque and strength 
per unit of muscle mass reduces with age (Lindle, Metter et al. 1997).  Additionally, the age 
related declines in muscle size and strength can have negative implications on the independence 
of individuals as they age, with sarcopenic women having  3.6 times higher disability rates and 
men 4.1 times higher disability rates than those with greater levels of muscle mass 
(Baumgartner RN 1998). 
There are a multitude of factors that contribute to sarcopenia.  Some of these factors 
include changes in endocrine function (Balagopal, Proctor et al. 1997), increases in inflammatory 
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cytokines (Bruunsgaard and Pedersen 2003), mitochondrial dysfunction (Hiona and 
Leeuwenburgh 2008),  and neurogenic changes (Vandervoort and McComas 1986; Berger MJ 
2010).  However, in the aging population it is argued that the major contributors to sarcopenia 
are lack of exercise or “disuse”, as well as inadequate nutrition both in regards to caloric 
(Morley 2001) and/or protein intake (Campbell and Evans 1996; Campbell WW 2001). 
Regardless of mechanism, sarcopenia is a result of a negative net protein balance.  Negative 
protein balance can occur as a result of decreased  protein synthesis, increased muscle protein 
breakdown, or a combination of both. 
A common measure of examining whole body protein balance is through nitrogen 
balance (NBAL).  Since amino acids are the main source of nitrogen (N) in the body, analysis of N 
intake through protein consumption compared to N losses can be used in calculating total body 
NBAL (Gropper 2009).  Thus, shifts in overall body NBAL are indicative of protein balance in the 
body.  A negative NBAL indicates a net loss of body protein, whereas a positive NBAL is 
indicative of a net gain of body protein. 
NBAL is largely dependent on both energy balance and protein intake.  Energy 
restriction leads to a decreased NBAL (Todd, Butterfield et al. 1984; Friedlander, Braun et al. 
2005), with increased amino acid oxidation occurring to meet energy needs.  However, there is 
evidence that increased protein intake is helpful in maintaining NBAL.  Specifically, 0.92 g of 
protein/kg bw has been shown to be superior than 0.45 g of protein/kg bw at maintaining NBAL, 
lean body mass (LBM), muscular strength, and immune function in elderly women over the 
course of 9 weeks (Castaneda, Charnley et al. 1995).  However, even in the presence of 
adequate protein intake, inadequate energy intake results in lower NBAL than when energy 
balance is maintained (Calloway and Spector 1954).  Conversely, increasing energy intake will 
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lead to an increased NBAL due to protein sparing effects (Munro 1951; Butterfield and Calloway 
1984).  Since protein synthesis is energetically costly and is dependent on ATP availability (Proud 
2002), elderly individuals who increase their energy intake will reduce their dependence on 
amino acids for energy purposes so they can be used for synthetic pathways.  Since NBAL is 
influenced largely by energy balance and protein intake, it seems an intuitive strategy for older 
individuals to focus on ingesting adequate calories and dietary protein to improve NBAL. 
Exercise is another proposed method to increase protein balance.  Although resistance 
training has been shown to increase muscle size and strength in older individuals (Frontera, 
Meredith et al. 1988), many older individuals are unable to perform resistance training due to 
prior injury, limited access to equipment, and lack of knowledge regarding proper technique.  
Fortunately, aerobic exercise (3 hrs @75 %VO2max) has been shown to increase whole body 
protein synthesis (WBPS) following exercise, with whole body protein breakdown (WBPB) not 
differing from values at rest (Devlin, Brodsky et al. 1990).  A long-term aerobic exercise program 
has been shown to increase basal whole protein turnover (WBPT) (Lamont, Patel et al. 1990), 
while decreasing leucine oxidation at rest (Gaine, Viesselman et al. 2005).  Additionally, it has 
been shown that prolonged aerobic exercise can increase myofiber size in elderly women 
(Harber, Konopka et al. 2009), thus providing evidence of the benefits of aerobic exercise at 
increasing LBM in elderly individuals.  Aerobic exercise’s effects on NBAL are also largely 
dependent on energy balance.  When individuals maintain energy balance, aerobic exercise 
increases NBAL over time (Todd, Butterfield et al. 1984; Gaine, Viesselman et al. 2005).  
However, the increases in NBAL observed from aerobic exercise are decreased when individuals 
are in a hypocaloric state (Todd, Butterfield et al. 1984).  Regardless of energy status, in the 
absence of nutrient intake protein balance will remain negative for up to 3 hours post exercise. 
(Biolo, Maggi et al. 1995). 
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Combining exercise with proper nutritional strategies has been proposed to be more 
effective than either intervention alone in stimulating muscle protein synthesis (MPS) (Biolo, 
Tipton et al. 1997; Miller 2007), and in treating sarcopenia.  Ingestion of amino acids with or 
without carbohydrate causes a shift towards increased protein balance post exercise (Biolo, 
Tipton et al. 1997; Miller, Tipton et al. 2003; Borsheim, Aarsland et al. 2004).  However, by 
consuming amino acids with carbohydrates post exercise, net protein balance can be increased 
to levels greater than if the amino acids or carbohydrate were ingestion alone (Miller, Tipton et 
al. 2003; Borsheim, Aarsland et al. 2004).  In the elderly, protein combined with carbohydrate 
(40g carbohydrate, 20g whey) leads to increases in WBPT in the elderly above those observed 
with an isoenergetic amount of carbohydrate (60g carbohydrate) (Murphy and Miller 2010). 
The timing of amino acid and carbohydrate ingestion has an influence on the degree of 
increase in protein balance.  The consumption of an oral supplement (10g protein, 8g 
carbohydrate, 3g fat) consumed immediately after aerobic exercise resulted in greater increases 
in MPS than if consumed 3 hours after exercise (Levenhagen, Gresham et al. 2001).  Our lab has 
previously shown that in older individuals in energy balance, consumption of protein and 
carbohydrates (chocolate milk) immediately following moderate aerobic exercise at 55% 
VO2max leads to greater NBAL than if consumed earlier in the day.  Our findings were 
particularly significant due to the fact that both trials were isocaloric and isonitrogenous, with 
only the timing of the protein intake differing.   Since increased energy intake also leads to 
increases in NBAL (Munro 1951; Butterfield and Calloway 1984), our lab wished to investigate 





Statement of the Problem: 
To determine if protein intake immediately following moderate intensity aerobic exercise 
increases NBAL to a greater degree than consuming the protein earlier in the day in hypercaloric 
older individuals. 
Hypothesis: 
While in positive energy balance, consumption of chocolate milk immediately after moderate 
aerobic exercise will increase 3-day NBAL more so than if consumed earlier in the day. 
Delimitations, Limitations, and Assumptions: 
The present study is delimited to 6 male (n=2) and female subjects (n=4) aged 55-75 
years old.  Subjects were recruited from Loveland and Fort Collins.  Since milk consumption is a 
major component of the study all of the subjects had to be tolerant of lactose. 
There are limitations of the NBAL technique, including the potential to overestimate 
NBAL (DM 1976).  Despite this, the NBAL technique was used under both control and 
experimental conditions, so the same magnitude of error existed under both conditions. 
It’s assumed that subjects fast for 12-hours prior to resting metabolic rate testing in the 
pretesting portion of the study methods.  During the lead-in and inpatient periods, it’s assumed 





Section 1: Implications of Sarcopenia 
Sarcopenia is a condition characterized by a decrease in strength and lean body mass as 
individuals age.  Sarcopenia’s prevalence is 13-24% in individuals under the age of 70 and more 
than 50% of individuals over the age of 80 (Baumgartner RN 1998).  In Greek, “sarcx” means 
flesh, and “penia” means deficiency (IH 1989).  The definition describes a decrease in muscle 
protein content, force production, fatigue resistance, and a corresponding decrease in muscle 
fiber diameter (Jackman RW 2004).  Although there is no universally accepted definition of 
sarcopenia (Berger MJ 2010), some define sarcopenia as the loss of LBM greater than two 
standard deviations (SD) from the mean of young controls (Baumgartner RN 1998). 
It has been shown that total muscle CSA declines by approximately 40% from the age of 
20 to 80 (Berger MJ 2010).  The correlation between muscle mass and strength has been shown 
in multiple studies (Fiatarone, Marks et al. 1990; Frontera, Hughes et al. 1991), such that the 
loss of muscle mass leads to an approximate 1.0% decrease in strength per year after the fourth 
decade of life (Doherty 2003).  When motor nerves of elderly individuals are electrically 
stimulated during voluntary maximal contraction no additional torque is produced (Vandervoort 
and McComas 1986).  Thus, declines in strength observed with aging seem to have more to do 
with muscle atrophy rather than the inability to stimulate motor neurons.   
7 
 
Elderly populations in their seventh and eighth decade exhibit an average strength 
decrease of 20-40% in their knee extensors when compared to younger populations, with 
relative strength losses similar for muscles of the upper and lower extremities (Berger MJ 2010).  
Although men and women vary little in their relative strength declines, men tend to have a 
larger absolute drop in strength since they tend to start at a higher baseline of strength than 
women (Berger MJ 2010).  These age related decreases in muscle CSA and strength lead to an 
overall decrease in MQ, which refers to strength per unit of muscle mass.  When corrected for a 
decline in absolute muscle mass, the amount of peak torque and strength per unit of muscle 
mass reduces with age (Lindle, Metter et al. 1997).  This decline in peak torque and strength 
implies a decrease in MQ and efficiency throughout the aging process.  The potential decrease 
in MQ is important since MQ is argued to be a better indicator of muscle function than just 
strength alone (Roubenoff and Hughes 2000). 
Data clearly demonstrates that a decrease in muscular strength inhibits mobility, and 
increase risk for injury and dependence.  Women and men with sarcopenia have 3.6 and 4.1, 
respectively, greater disability rates than younger controls (Baumgartner RN 1998).  In addition, 
it has been shown in nursing home residents with two or more documented falls, that the 
“fallers” have weaker ankle and knee flexion than the “non-fallers” control group (Wolfson, 
Judge et al. 1995).  
Sarcopenia also reduces resting metabolic rate (RMR). LBM is the largest factor 
contributing to an individual’s RMR (Miller and Blyth 1953), therefore losses of LBM via the 
onset and progression of sarcopenia may contribute to a decline in RMR (Tzankoff and Norris 
1977).  Reduced RMR makes elderly individuals more susceptible to the numerous negative 
health implications associated with excess body fat.  There is a decrease of 13-20% in RMR 
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between age 30 and age 80, with men having a larger decrease along with earlier onset of 
decline in RMR (Wilson MM 2003). Additional contributors to a declining RMR include a 
decrease in Na+/K+-ATPase activity and decreases in membrane permeability within the 
mitochondria (Wilson MM 2003). When exposed to overfeeding, older individuals also 
experience a smaller compensatory increase in their RMR than younger populations.  By 
maintaining or attenuating age-related reductions in LBM, older individuals may be less 
susceptible to fat gain.  
Later, the review of literature will discuss the mechanisms leading to sarcopenia.  
Regardless of mechanism, the underlying end result is a net loss in muscle protein because 
protein synthesis is exceeded by protein breakdown. To understand these processes, protein 
metabolism will be discussed first. 
Section 2: Protein Metabolism 
In Greek the protein root “proteos” means “primary”, or “taking place first” (Gropper 
2009).  Forty percent of total body protein mass is found in skeletal muscle, 25% in body organs, 
and the rest primarily in skin and blood (Gropper 2009). The processes of protein synthesis and 
protein breakdown are termed protein turnover and will be discussed in further detail in the 
“Protein Turnover” section. 
There are 20 different amino acids, which are used to build proteins.  Nine of the amino 
acids are considered “essential”, which means they must be obtained from dietary sources.  The 
rest of the amino acids are considered “nonessential”, which means they can be synthesized in 
the body (Houston 2006).  All amino acids share the same type of basic structure, including a 
carbon (C), at least one carboxyl (acid) group (-COOH), and at least one amino group (-NH2).  The 
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differences between amino acids are due to their varying side chains, known as the R-group 
(Gropper 2009).  
Amino acids are liberated during the digestion of dietary protein.  Like carbohydrate, 
dietary protein provides   4 kcal g of physiological energy.  Protein digestion begins in the 
stomach, where hydrogen and electrostatic bonds are broken by hydrochloric acid (HCI), causing 
an unfolding of the protein.  Pepsin then hydrolyzes the peptide bonds of the protein, resulting 
in large polypeptides, oligopeptides, and free amino acids which then enter the small intestine.  
Once in the small intestine, proenzymes and zymogens are converted to active enzymes that 
further hydrolyze the peptide bonds.  The final products of digestion are dipeptides, tripeptides, 
and amino acids, which are then absorbed across the brush border of the small intestine into 
enterocytes. If unused, the amino acids are then transported into the interstitial fluid where 
they enter the villi’s capillaries and the portal vein on their way to the liver (Gropper 2009).  The 
liver has the ability to synthesize nonessential amino acids that can be utilized in the liver or to 
keep a balance in the what is called the amino acid pool (Houston 2006).  
 The amino acid pool is used to make new proteins.  The amino acid pool is supplied and 
regulated through protein intake, protein synthesis and protein breakdown of tissues, and the 
synthesis and release of amino acids by the liver (Houston 2006).  The whole-body amino acid 
pool is about 150g.  It is thought that endogenous amino acids are the primary source of amino 
acids taking part in protein synthesis (Gropper 2009). Amino acids in the pool that are in excess 
of what is required for protein synthesis of new proteins and non-protein N containing 
molecules are generally oxidized for energy (Gropper 2009).   
When used for energy, amino acids first lose their amino group and other N atoms.  The 
carbon skeleton can then be used to make glucose via gluconeogenesis in the liver, converted to 
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acetyl-CoA for entry into the citric acid cycle (TCA), or used to synthesize fatty acids via 
lipogenesis.  The liver is responsible for removing the amino groups in a process called 
deamination.  Skeletal muscle however, has a specific capacity to deaminate branched-chain 
amino acids (BCAA), which consist of leucine, isoleucine, and valine (Houston 2006).  In 
deamination, the amino groups are removed without being transferred to another amino acid, 
which generates ATP.  This process results in the creation of an α-keto acid.  Oxidative 
deamination creates ammonia, which must be disposed of through the urea cycle, which will be 
covered in the “Nitrogen Balance” section.  Transamination can transfer the amino group to a 
carbon skeleton or an existing  α-keto acid, in order to synthesize a new non essential amino 
acid (Gropper 2009). 
To summarize, the consumption of dietary protein yields amino acids, which enter an 
amino acid pool for the eventual synthesis of proteins, transamination, or production of energy.  
Section 3: Protein Turnover 
Protein turnover refers to the continuous process of the synthesis of new proteins from 
amino acids and degradation of proteins into individual amino acids.  Protein turnover is 
necessary to preserve the function of body proteins.  In terms of magnitude of contribution, 
skeletal muscle contributes slightly less than 30% of the whole body protein turnover (WBPT) 
rate (Nair 1995).  It is energetically costly to make and breakdown proteins and WBPT has been 
shown to account for approximately 20% of an individual’s  RMR (Welle and Nair 1990).  
There are many reasons for protein turnover in the body.  Modified or wrongly 
translated proteins may be destroyed to prevent cellular damage.  Additionally, when energy 
intake is deficient, proteins may be oxidized to meet energy requirements.  Energy deficient 
states can be observed in both the post absorptive and fasting states, where protein breakdown 
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is elevated and protein synthesis is diminished.  Changes in the rates of protein turnover also 
allow humans to adapt to an altered environmental or nutritional condition (Houston 2006).  For 
example, increases in dietary protein intake have been shown to lead to increases in WBPT in 
elderly individuals (Pannemans, Halliday et al. 1995), with increases in WBPT and NBAL observed 
when dietary protein intake is increased in young subjects (Pannemans, Halliday et al. 1995).  
There is a need to further study WBPT in elderly individuals, since approximately 30% of total 
body protein can be attributed to skeletal muscle (Cohn, Vartsky et al. 1980), with the 
remainder incorporated into non-muscle tissues.  Although sarcopenia is largely a result of 
decreased skeletal muscle protein turnover, the present study examines NBAL, a WBPT 
measure. 
Wasting results from a negative net protein balance, which is a result of decreased 
protein synthesis, increased protein breakdown, or a combination of both.  It has been shown 
that per kilogram (kg) of bodyweight (bw) that elderly individuals have diminished protein 
turnover rates compared to younger individuals (Morais, Gougeon et al. 1997). Differences in 
protein turnover per kg/bw may be due changes in body composition since no difference in 
protein turnover was seen when corrected per unit of fat free mass (FFM) (Morais, Gougeon et 
al. 1997).  However, another study found that even when corrected for FFM, elderly individuals 
experience a 20% reduction in WBPT compared to their younger counterparts (Balagopal, 
Rooyackers et al. 1997).  
Section 3.1: Protein Synthesis 
 The process of protein synthesis occurs in the cell’s cytosol, and begins with messenger 
ribonucleic acid (mRNA) following post-transcriptional modifications of ribonucleic acid (RNA) 
from deoxyribonucleic acid (DNA) transcription.  The mRNA’s sequence of nucleotide bases 
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determines the amino acid sequence when forming a peptide chain.  Amino acids are attached 
to specific transfer ribonucleic acid (tRNA).  Every tRNA contains an anticodon and amino acid, 
which combines with codons on mRNA, providing the amino acid to the protein sequence.  
During translation initiation, the formation of a complete ribosomal subunit occurs at the start 
codon (AUG) on mRNA with tRNA and its amino acid (Houston 2006).  A number of eukaryotic 
initiation factors (eIFs) play a role in this initiation process (Wang and Proud 2006), such as 
recruiting the mRNA to the 40S ribosomal subunit (Gingras, Raught et al. 1999), as well as 
recruiting methionyl-tRNA (Met-tRNA1), which together inspect the 5’-untranslated region of 
the mRNA for the start codon (Wang and Proud 2006).  
 During elongation, tRNA arrives at the ribosomal complex, three bases at a time, with 
the associated coded amino acids and form peptide bonds with the preceding amino acid.  The 
energy required for elongation comes from the hydrolysis of GTP to GDP and Pi.  The process of 
elongation continues, with the growing of a peptide chain until the stop codon (UAG, UGA, or 
UAA) is reached on the mRNA molecule.  Eukaryotic elongation factors (eEFs) participate in the 
elongation process, by assisting in the translocation of the tRNA to and along the ribosomal 
complex.  The peptide chain is released once the ribosomal complex is removed from the mRNA 
using energy from GTP hydrolysis (Houston 2006). 
Section 3.2: Protein Breakdown 
 Protein breakdown processes occur via proteinases, which are protein degrading 
enzymes.  These enzymes act primarily through the ubiquitin-proteasome pathway, the 
lysosomal system, and the calpain system (Houston 2006).  
The ubiquitin-proteasome pathway recognizes specific proteins for degradation.  The 
covalent attachment of ubiquitin, a small protein, allows for this recognition to occur.  Once 
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ubiquination occurs, proteins are broken down to polypeptides via a 26s proteasome complex.  
The polypeptides are broken down by proteases, which release small peptides that are then 
degraded to amino acids by cytosolic peptidases.   During exercise there is a decrease in activity 
of the ubiquitin-proteasome pathway (Houston 2006).  The decreased activity of the ubiquitin-
proteasome pathway  is important, since the pathway is thought to account primarily for the 
degradation of myofibrillar proteins (Taillandier, Combaret et al. 2004). 
Lysosomes are organelles that contain cathepsins, which are protein degrading 
enzymes.  Cathepsins break the peptide bonds on the interior of a protein molecule. 
Additionally, lysosomes possess proteinases that cleave individual amino acids.  Proteins must 
enter the lysosomal system via endocytosis for degradation (Houston 2006). 
The calpain system involves calcium-activated proteinases in the cell cytosol.  These 
proteinases are activated by increases in the concentration of intracellular calcium.  The 
proteinases are thought to be activated by the increased calcium concentrations from muscular 
contraction during exercise.  The calpain system acts on structural proteins in muscle (Houston 
2006), and contributes to muscle breakdown by cleaving cytoskeletal and myofibrillar proteins 
(Belcastro, Shewchuk et al. 1998).  
Although muscle protein breakdown (MPB) is a large player in the protein balance 
equation, age is correlated with decreased MPB with a greater reduction seen in women 
(Morais, Gougeon et al. 1997).  The decreased MPB observed in aging men and women provides 





Section 3.3: Assessing Protein Turnover  
 There are a number of methods that assess protein turnover.  These methods either 
take into consideration the whole body or the skeletal muscle specifically. 
Both WBPT and MPS can be assessed using stable isotopes.  By using labeled amino 
acids and introducing them into the plasma, isotopic ratios in the plasma can be assessed to 
determine WBPT (Garlick and Cersosimo 1997).  MPS can be directly measured through the use 
of tracers such as leucine (Nair, Halliday et al. 1988; Welle, Thornton et al. 1995; Balagopal, 
Rooyackers et al. 1997; Miller, Olesen et al. 2005) or phenylalanine (Phillips, Tipton et al. 1997; 
Volpi, Mittendorfer et al. 1999; Volpi, Sheffield-Moore et al. 2001).  These “precursor: product 
labeling” techniques work by allowing the tracer and amino acid to incorporate into the amino 
acid pool. This pool supplies amino acids to MPS, and the tracer and amino acid are 
incorporated into skeletal muscle (Gasier, Fluckey et al. 2010). Due to the necessity of a 
controlled environment for tracer infusion, and short term nature of the measurements, tracer 
methods are unable to be administered in a free-living conditions (Gasier, Fluckey et al. 2010). 
In an attempt to directly measure protein synthesis in free-living conditions, the use of 
tracers such as 2H2O have also been used.  By consuming 
2H2O, deuterium is incorporated into 
free amino acids through intermediary metabolism from body water.  Like the previously 
described tracer techniques, these labeled amino acids are incorporated into skeletal muscle 
following MPS (Robinson, Turner et al. 2011).  2H2O offers a distinct advantage in that it can be 
consumed orally rather than needing to be infused (Belloto, Diraison et al. 2007).  However, 
2H2O is best suited for longer-term studies.  
MPB is more difficult to directly measure, but techniques are available. MPB is 
commonly measured in vivo via 3-Methylhistidine (3-MeH) excretion in urine (Ballard and Tomas 
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1983). 3-MeH is a component of the myofibrillar proteins actin (Asatoor and Armstrong 1967), 
and myosin (Johnson, Harris et al. 1967).  Since 3-MeH is unique to actin and myosin, increases 
in 3-MeH excretion is indicative of increased MPB in vivo (Ballard and Tomas 1983).  
Additionally, the use of tracers can be can be utilized and measured for “arterio-venous 
difference” to  asses MPB as a component within the skeletal muscle protein turnover 
(Wagenmakers 1999). The “arterio-venous difference” method can be challenging since it 
requires a great degree of analytical precision and consistency in blood flow through the muscle 
tissue (Macdonald 1999). 
Section 3.4: Nitrogen Balance 
Measuring the body’s NBAL is a common method to assess an individual’s WBPT.  Amino 
acids are the main source of  N in the body, with N comprising approximately 16% of the 
average mass of most proteins (Gropper 2009).  Therefore, shifts in overall body NBAL is 
indicative of protein balance in the body. A negative NBAL indicates a net loss of body protein, 
whereas a positive NBAL is indicative of a net gain of body protein.  By subtracting N losses from 
N intake through diet, total body NBAL can be calculated (Gropper 2009). In order to calculate 
NBAL, N intake and N output must be measured. In terms of N intake, 6.25 g of protein is 
assumed to contain 1 g of N, thus a daily intake of 70 g of protein would provide 11.2 g of N 
(Gropper 2009).  Measurement of N output is more complicated, and relies on some 
assumptions, which will be discussed. 
In discussing the methods of measuring N output, the urea cycle must first be discussed.  
The urea cycle disposes of excess N.  As mentioned previously, amino acids that are not used for 
protein synthesis are typically oxidized, liberating amino acids (Gropper 2009).  The carbon 
skeletons of the amino acids can be used to either make glucose via gluconeogenesis in the liver,  
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be converted to acetyl coA for entry into the citric acid cycle (TCA cycle) or be used for fat 
synthesis.  In the process of deamination, the amino group is transferred to α-ketoglutarate 
forming glutamate, or from glutamate to a keto acid, thus creating a new amino acid and new 
keto acid.  The resulting amino groups are removed as urea in the liver.  The amino group on 
glutamate is first transferred to the liver, and incorporated into the urea molecule, which 
contains two amino groups.  The N from the glutamate is released as ammonia via the 
glutamate dehydrogenase reaction in the liver (Houston 2006).  This oxidative deamination 
reaction is depicted below: 
glutamate + H2O + NAD
+
α-ketoglutarate + NADH + H+ + NH4+ (Houston 2006) 
Although ammonia can exist safely in the form of the amino group on glutamate and in 
the side chain of glutamine, it is otherwise toxic, especially to the brain.  Following urea 
formation, it is excreted from the kidney with formation of urine. The N in urea comes from 
protonated ammonia or from the amino group from aspartate. This ammonia comes from the 
blood via protein breakdown, from glutamine, or from glutamate in the glutamate 
dehydrogenase reaction discussed above. The aspartate, on the other hand, comes from the 
transamination reaction of oxaloacetate from glutamate, resulting in the formation of aspartate 
and α-ketoglutarate (Houston 2006).  
The actual formation of urea consists of a number of enzymatic steps.  These steps 
occur in both the mitochondrial matrix and cytosol of liver cells.  The first step in the process 
occurs in the mitochondrial matrix and involves the formation of carbamoyl phosphate from 
ammonia and carbon dioxide.  This step is catalyzed via carbamoyl phosphate synthetase, and is 
the rate limiting step in the formation of urea.  When MPB is accelerated, carbamoyl phosphate 
synthetase is allosterically controlled by N-acetyl glutamate and increases flux through the urea 
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cycle.  Once carbamoyl phosphate enters the urea cycle it joins with ornithine, forming citrulline 
via ornithine transcarbamoylase.  Once aspartate enters the urea cycle it joins citrulline, forming 
argininosuccinate via argininosuccinatesynthetase in the mitochondrial matrix. This 
argininosuccinate is then split forming arginine and fumarate via argininosuccinatelysase.  
Finally, arginine is split via arginase and subsequently forms ornithine and urea. While the 
ornithine goes onto assist in the first step of the urea cycle, the urea leaves the liver through 
blood entering the kidneys (Houston 2006). Finally, the urea is excreted in urine and can be 
measured for N.  
Of total N losses in the body, 80% of the N is lost in the urine under normal conditions. 
Other urinary sources of N include ammonia, creatinine, uric acid, with trace N losses also seen 
in amino acids, and hippuric acid.  Losses of N are also seen in urea in sweat, as well as hair, skin, 
and fecal N losses (Gropper 2009).  These losses are considered miscellaneous N losses. 
The equation commonly used in calculating NBAL is: 
NBAL (g)= N intake (calculated via protein consumption) - (fecal N + urinary N (directly 
measured) + misc. N loss)  
Both fecal N and misc. N are estimates, of 2g/day (Calloway, Odell et al. 1971) and 5 mg/kg 
bw/day (Calloway, Odell et al. 1971), respectively.  When adequate protein is ingested the N 
balance should be zero (equilibrium) under normal weight stable conditions.  
 There are drawbacks to the use of the NBAL technique when examining WBPT.  The 
NBAL technique is not able to distinguish between relative contributions between protein 
synthesis and protein breakdown as it relates to increases or decreases in NBAL. Thus, it is 
impossible to know that an increase or decrease in N retention by the body is a result of 
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increased or decreased protein synthesis, decreased or increased protein breakdown, or a 
combination of both.   
A second criticism is that NBAL overestimates N retention due to underestimations of N 
output (Kopple 1987).  The exact amount of N output via fecal and miscellaneous N losses are 
commonly estimated due to impractical methods of collection.  Additionally, N losses from 
brushing one’s teeth, toilet paper, and exhaled ammonia are typically ignored (Calloway, Odell 
et al. 1971).  With this number of miscellaneous N sources, there is a larger potential for 
variability.  For example, N from sweat has shown in to be quite variable (Consolazio, Nelson et 
al. 1963; Consolazio, Matoush et al. 1966; Ashworth and Harrower 1967).  Increasing protein 
intake also increases sweat N output (Cuthbertson and Guthrie 1934).  However, these 
inaccuracies can be minimized by testing subjects under the same conditions when doing the 
intervention.  
If the NBAL technique is employed it may be prudent to have individuals participate in a 
dietary lead in period.  The lead in period allows NBAL to adjust to the new protein intake, since 
it has been shown to take approximately a week (2007). However, additional research has 
shown that acute changes in protein intake (within ± 4% of habitual intake) does not lead to 
significant changes in WBPB, MPS, or muscle proteolytic enzymes. These lack of significant 
changes provide evidence that a lead in period may not be as necessary as previously thought 
(Yarasheski, Castaneda-Sceppa et al. 2011). 
Despite the limitations of the NBAL technique, it is easy to employ and provides valuable 
information regarding the whole body protein balance in the body.  Unlike the leucine and 
phenylalanine tracer methods, the NBAL method can study WBPT over multiple days.  
Additionally, the NBAL method incorporates all activities of daily living in free living individuals.  
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Its noninvasive nature makes it an appealing method in studying the aging population.  The 
NBAL technique can be used to determine adequate protein intakes, and changes in NBAL and 
WBPT can be analyzed with regards to the effects of exercise and nutritional interventions.   
Section 4: Interrelationship between energy balance and protein intake on NBAL 
NBAL is dependent on both energy balance and protein intake.  Regarding energy 
balance, it is common for individuals to decrease their energy intake as they age (Morley and 
Silver 1988).  The decreased energy intake can have negative implications, with energy 
restriction resulting in a decreased NBAL (Todd, Butterfield et al. 1984; Friedlander, Braun et al. 
2005).  Fasting for ≤4 days increases leucine oxidation (Knapik, Meredith et al. 1991), total 
leucine flux and proteolysis (Tsalikian, Howard et al. 1984), which can lead to losses in LBM. 
Amino acid oxidation is increased during fasting to meet energy demands, with skeletal muscle 
providing disposable AAs to maintain proteins in more vital organs.  Specifically, it has been 
shown that dietary restricted rats preserve the protein synthetic rate of the heart, whereas MPS 
is reduced in both acute and chronic restriction scenarios (Yuan, Sharma et al. 2008).  The 
decrease in MPS and increase in MPB with negative energy balance leads to losses of LBM 
(Friedlander, Braun et al. 2005).   
Conversely, increased energy intake spares protein resulting in a more positive NBAL 
(Munro 1951; Butterfield and Calloway 1984).  When additional carbohydrate or fat is added to 
an adequate energy and protein intake, NBAL will increase (Munro 1951).  Supplying 700 non-
protein calories has been shown to maximally spare N losses in the absence of dietary protein. 
However, when ample N is  provided but there are inadequate non-protein calories, NBAL will 
not be maintained (Calloway and Spector 1954).  Added energy intake will also increase NBAL if 
the added energy is balanced with an equal amount of energy expenditure (EE) through exercise 
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(Butterfield and Calloway 1984).  Protein synthesis is dependent on ATP availability, and is 
extremely energetically costly (Proud 2002).  Increasing energy intake reduces the dependence 
on amino acids for energy purposes so they can be used for synthesis of new proteins. 
Conversely, during an energy deficit, protein synthesis is down regulated due to its energetically 
costly nature.  
Dietary protein intake also has an impact on NBAL. NBAL is extremely adaptive, with 
urinary N equilibrium occurring after an average of 8 days into a protein free diet (Rand, Young 
et al. 1976).  Despite the ability of the body to adapt to reductions in dietary protein, insufficient 
dietary protein can lead to a number of negative consequences. Specifically, it has been shown 
that 0.45 g/kg bw is inferior to 0.92 g/kg bw in maintaining NBAL, LBM, muscular strength, and 
immune function in elderly women over the course of 9 weeks (Castaneda, Charnley et al. 
1995).  Additionally, it was shown that exercise in the presence of a protein intake below the 
Recommended Dietary Allowance (RDA) (0.57 g/kg bw), results in less N retention than if the 
person is consuming the RDA for protein (0.8 g/kg bw) (Todd, Butterfield et al. 1984).  By 
increasing dietary protein intake individuals can increase NBAL in circumstances of both dietary 
(Calloway and Spector 1954), and exercise induced (Pikosky, Smith et al. 2008) energy deficits.  
Therefore, it appears that increases in protein intake have a compensatory effect on attenuating 
or eliminating the decreases in NBAL observed with negative energy balance.  Maintaining 
protein intake will not totally negate the effects on NBAL observed with negative energy 
balance.  Even if an individual is consuming their habitual protein intake, the presence of 
negative energy balance can result in a decrease in NBAL (Iyengar and Narasinga Rao 1979).  
Therefore, it is likely that maintaining adequate caloric intake is more important than consuming 
adequate protein in maintaining NBAL. 
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It is debated whether the RDA for protein is adequate for elderly adults.  The current 
RDA for protein is 0.8 g/kg bw per day for both men and women aged 19 years and older 
(Campbell, Johnson et al. 2008).  At the time the RDA was established, little data was available 
regarding protein requirements in the elderly.  The present recommendation is based on NBAL 
data collected in younger subjects.  Recently, when young and old individuals were compared 
during three 18 day trials at 0.5, 0.75, and 1.00 g protein/kg bw, there were no observed 
differences in NBAL between young and old individuals (Campbell, Johnson et al. 2008).  An 
additional study examined older men and women consuming the RDA for protein while in 
energy balance for 30 days.  An observed negative NBAL was seen in some of the subjects during 
the final 5 days of the month long study (Gersovitz, Motil et al. 1982), which indicated that 
longer-term interventions may be necessary to determine the adequacy of the protein RDA in 
older populations.  One such long-term study provided 0.8 g protein/kg bw/day (RDA) paired 
with sufficient energy intake so that bodyweight was not changed over the course of 14 weeks 
in men and women aged 55-77 years old.  The researchers found that urinary N excretion 
actually decreased throughout the study, providing evidence of NBAL adaptation (Campbell WW 
2001).  There were also no significant changes in protein turnover, oxidation, and synthesis over 
time.  However, measurements of mid-thigh muscle area decreased significantly over the course 
of the 14 week study (Campbell WW 2001).  
As discussed, NBAL is influenced largely by energy balance and protein intake. It seems 
an intuitive strategy for older individuals to focus on ingesting adequate calories and dietary 





Section 5: Anabolic Resistance in Elderly 
 As mentioned previously, the onset and progression of wasting can be attributed to a 
number of interrelated factors.  However, of primary importance, is that aging individuals have a 
degree of “anabolic resistance” to stimuli that promote protein synthesis.  Before discussing the 
observed anabolic resistance in the elderly, it is necessary to discuss the mammalian target of 
rapamycin-signaling pathway (mTOR) and its regulation on metabolism and growth.  
Section 5.1: The mTOR Pathway 
 mTOR is a multidomain protein that plays a role in both cellular metabolism and 
hypertrophic growth through the control of protein synthesis.   mTOR interacts with a number 
of protein partners that regulate its function.  Two of the binding partners for mTOR are raptor 
and rictor, which assist in the forming of the mTOR1 and mTOR2 complexes, respectively.  
Raptor interacts with proteins regulated by mTOR in a rapamycin sensitive manner. These 
targets possess TOR signaling motifs (TOS motifs) , which contain 4E binding proteins (4E-BPs) 
and S6 kinase (S6K’s) involved in the translation phase of protein synthesis (Wang and Proud 
2006).   
 mRNA translation can be described in three steps: initiation, elongation, and 
termination. The mTOR pathway controls protein synthesis via the initiation and elongation 
phases of the synthetic process.  Translation initiation is mediated through the actions of eIFs, as 
briefly discussed previously.  Specifically, eIF4E is responsible for binding to the 5’-cap end of the 
mRNA, and recruiting the 40S ribosomal subunit and Met-tRNA to locate a start codon (Gingras, 
Raught et al. 1999).  eIF4E also binds to eIF4G which binds to poly(A)-binding protein (PABP), 
circularizing the mRNA (Wang and Proud 2006).  eIF4E binds to phosphoproteins called 4E 
binding proteins (4E-BPs).  One particular 4E-BP, 4E-BP1, binds to the same region of eIF4E as 
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eIF4G, so the binding of  4E-BP1 to eIF4E prevents eIF4E binding to eIF4G, thus inhibiting 
translation initiation complexes (Gingras, Raught et al. 1999). 4E-BP1 phosphorylation can 
impair eIF4E binding, depending on the site of phosphorylation.  mTOR is thought to be 
responsible for the phosphorylation of 4E-BP1, thus releasing eIF4E so it is able to bind to eIF4G 
for translation initiation.  Another eIF, eIF4B, is a substrate for phosphorylation by mTOR 
regulated S6 kinases (S6K’s) (Lawson, Lee et al. 1989; Raught, Peiretti et al. 2004).  eIF4B 
stimulates RNA helicase activity through interaction with eIF4A (Lawson, Lee et al. 1989).  
Phosphorylation is thought to stimulate its function (Wang and Proud 2006), by recruiting 
ribosomes to the 5’ end of the mRNA (Holz, Ballif et al. 2005), where eIF4B stimulated RNA 
unwinding can occur during translation initiation (Wang and Proud 2006). 
Translation elongation requires elongation factors, eEF1 and eEF2, with the latter being 
controlled by signaling through the mTOR pathway.  eEF2 promotes translocation, in which the 
ribosome moves along subsequent codons of the mRNA following the formation of peptide 
bonds (Wang and Proud 2006).  Phosphorylation of eEF2 through eEF2 kinase inhibits eEF2 
binding to the ribosome, impairing elongation (Carlberg, Nilsson et al. 1990).  mTOR regulated 
S6K1 can phosphorylate eEF2 kinase , inhibiting eEF2 kinase action (Wang and Proud 2006).  
Protein synthesis is dependent on ATP availability and is energetically costly (Proud 
2002).  Of particular importance regarding energy balance and protein synthesis is AMP kinase 
(AMPK).  During an energy deficit, AMPK is activated due to a rise in AMP and a decrease in the 
ATP/AMP ratio.  AMPK decreases the energetically costly process of protein synthesis by 
forming the tuberous sclerosis complex (TSC1/TSC2 complex), which is an inhibitor of the mTOR 
pathway (Inoki, Zhu et al. 2003).  Conversely, mTOR can be stimulated by an energy surplus and 
the availability of ATP and AAs for protein synthesis.  Following feeding, mTOR can be stimulated 
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both by insulin and by essential amino acids (EAAs).  Insulin is believed to exert its effects by 
increasing phosphatidylinositol 3-kinase (P13K) and protein kinase B (Akt/PKB) activity.  Akt 
phosphorylates the tuberous sclerosis complex (TSC2 complex), thus increasing mTOR activity 
(Fujita, Dreyer et al. 2007).  It is unclear how exactly EAAs activate the mTOR pathway.  
However, it has been shown that EAAs, in the absence of insulin, are capable of rapidly 
stimulating S6K1 and 4E-BP1.  In addition, there is evidence that EAAs stimulate upstream 
targets of mTOR such as human vacuolar protein sorting 34 (hVps34), which in turn drives S6K1 
activation (Gulati and Thomas 2007).  To conclude, mTOR is modulated by a number of 
nutritional signals and serves to either increase or decrease the rate of protein synthesis. 
Section 5.2: Nutritional Anabolic Resistance in Elderly 
 The age related losses in LBM observed with aging can largely be attributed to a blunted 
response to nutritional anabolic stimuli. Some research shows no differences in postabsorptive 
basal muscle protein turnover between young and old individuals (Volpi, Mittendorfer et al. 
1999; Volpi, Sheffield-Moore et al. 2001), however other research does demonstrate differences 
in basal MPS (Welle, Thornton et al. 1993; Yarasheski, Zachwieja et al. 1993). Mixed results 
regarding postabsorptive protein turnover led to research investigating if an anabolic resistance 
is present in the elderly after feeding, which may contribute to the losses in LBM associated with 
aging.  
Essential amino acids up-regulate MPS in the postprandial state (Biolo, Tipton et al. 
1997; Cuthbertson, Smith et al. 2005).  It has since been observed that the rise in MPS observed 
from EAA ingestion without an associated increase in insulin signaling, is blunted in the elderly 
(Cuthbertson, Smith et al. 2005).  Mechanistically, it is believed this anabolic resistance to EAAs 
is due to decreased activation of mTOR, 4E-BP1, S6K1, and eIF2B (Cuthbertson, Smith et al. 
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2005).  Inhibition of mTOR mediated MPS in response to EAA feeding may result in a net loss of 
muscle protein and contribute to LBM reductions in the elderly. 
Additional research has been done to elucidate insulin’s role in MPS and MPB, as well as 
insulin’s effects in the elderly.  It is believed that amino acid availability is what drives MPS 
beyond an insulin concentration of ~10m IU.ml-1 (Cuthbertson, Smith et al. 2005).  In support of 
this, insulin in the range of ~30-170 m IU.ml-1 has no effect on MPS (Greenhaff, Karagounis et al. 
2008), with the presence of AAs appearing to be necessary for MPS to occur (Bell, Fujita et al. 
2005). However, insulin protects against MPB, with no additional effects observed beyond 30 m 
IU.ml-1 in young subjects (Greenhaff, Karagounis et al. 2008). Although basal leg protein 
breakdown (LPB) appears to be similar between young and old, older subjects seem to be 
resistant to insulin’s inhibitory effects on proteolysis (Wilkes, Selby et al. 2009).  Specifically at 
plasma insulin concentrations of 5 m IU.ml-1, younger subjects experienced a 35% greater 
reduction in LPB than older individuals (Wilkes, Selby et al. 2009).  
In response to mixed meal ingestion, the postprandial myofibrillar protein fractional 
synthesis rate is blunted in the elderly as compared to younger subjects (Welle, Thornton et al. 
1994).  It’s been shown that young individuals exposed to hyperaminoacidemia in conjunction 
with hyperinsulinemia experienced increases in MPS (Bennet, Connacher et al. 1990; Volpi, 
Mittendorfer et al. 2000), along with decreases in MPB (Volpi, Mittendorfer et al. 2000). 
However, older individuals exposed to the same protocol were shown to have a decreased 
anabolic response to hyperaminoacidemia and hyperinsulinemia compared to the younger 
individuals (Volpi, Mittendorfer et al. 2000).  The decreased anabolic response was due to no 
significant increase in MPS in the older individuals, although decreases in MPB were seen in 
both young and old (Volpi, Mittendorfer et al. 2000).  The decreases in MPB observed were 
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likely due to the hyperinsulinemic state, since amino acid administration in isolation has not 
been shown to reduce MPB in elderly individuals (Volpi, Ferrando et al. 1998).  To conclude, the 
diminished anabolic response to feeding may be a primary driver in the progression of wasting 
due to decreased rates of protein synthesis and prolonged negative protein balance. 
Section 6: Additional Contributing Factors to Sarcopenia 
Beyond the anabolic resistance to feeding observed in the elderly, there are a number 
of other factors that contribute to the progression of age associated wasting.  Intrinsic factors 
include hormonal influences, neuromuscular changes and muscle morphology, and 
mitochondrial dysfunction and oxidative stress.  Extrinsic contributors include reductions in 
physical activity, as well as inadequate energy intake. 
Section 6.1: Hormonal influences  
There are multiple hormonal influences within body that provide additional anabolic 
stimuli beyond those observed with feeding. In an aging population it is common to see 
decreases in endogenous anabolic hormones such as testosterone (van den Beld 2000), growth 
hormone, and IGF-1 (Rudman, Feller et al. 1990). 
Total testosterone decreases in individuals as they age.  Additionally, a large amount of 
the total testosterone is bound to sex hormone binding globulin (SHBG) or albumin, resulting in 
less free testosterone for anabolic uses (Morley and Perry 2000).  A 3% annual decline in free 
testosterone has been observed in males age 73-94, which appears to parallel the decreases in 
muscle size and strength observed in aging men (van den Beld 2000).  Testosterone replacement 
in older hypogonadal men has led to increases in lean body mass (LBM) (Tenover 1992). 
However, there are negative consequences seen with exogenous testosterone administration 
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such as prostate growth, specific antigens increase, increased hematocrit, and negative effects 
on lipid profiles (Morley and Perry 2000).  Postmenopausal women also experience decreases in 
free testosterone.  Additionally, those having undergone hysterectomy with oophorectomy have 
40% less total and free testosterone levels than those observed in the intact women (Laughlin, 
Barrett-Connor et al. 2000).  
Growth hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) also decrease with age 
(Rudman, Feller et al. 1990), and likely contribute to the age related declines in LBM.  GH is 
secreted from the pituitary gland and leads to peripheral production of IGF-1.  It has been 
shown in elderly males that exogenous GH administration to raise IGF-1 levels has a positive 
effect on increasing LBM along with decreases in fat mass  (Rudman, Feller et al. 1990).  
However, in elderly populations GH administration has shown both a positive (Butterfield, 
Thompson et al. 1997) effect on MPS, as well as no effect (Welle, Thornton et al. 1996) on both 
whole body protein synthesis or MPS.  It is speculated that individuals that are not deficient in 
GH observe no additional anabolic benefit from GH administration (Rennie 2003).  Additionally, 
there is evidence that resistance exercise in older men combined with exogenous growth 
hormone does not lead to greater increases in muscle strength, compared to resistance training 
alone (Taaffe, Pruitt et al. 1994).  IGF-1 administration can increase protein synthesis in the 
short-term (Butterfield, Thompson et al. 1997), however long-term administration does not lead 
to increases in LBM or strength in elderly women (Friedlander, Butterfield et al. 2001).   
Although there is a decrease in anabolic hormones during the aging process, there is 
recent evidence that testosterone, growth hormone, and IGF-1 have no significant role in the 
anabolic processes resulting from an acute bout of resistance training (West, Burd et al. 2010).  
Two types of resistance exercise protocols were compared, with one leading to significant acute 
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increases in testosterone, growth hormone, IGF-1, while the other protocol did not lead to acute 
increases in these anabolic hormones.  After 12-weeks, there was no significant difference in 
muscle CSA or strength between groups (West, Burd et al. 2010). The insignificant differences in 
muscle CSA and strength suggest that acute physiological increases in testosterone, growth 
hormone, and IGF-1 do not play a role in the anabolic response from resistance training. 
Section 6.2: Changes in Neuromuscular Functioning and muscle morphology 
Muscle denervation can lead to muscle atrophy.  Elderly individuals over age 60 can 
have as little as 50% of the motor neurons as their young and middle aged counterparts 
(Tomlinson and Irving 1977; Brown, Strong et al. 1988).  Following denervation, a muscle 
decreases its mass by over 50% within the first month (Gutmann 1962).  This denervation is 
thought to be a result of changes in the functional and structural integrity of the neuromuscular 
junction (NMJ).  Specifically, there is observed pre-terminal thinning, sprouting, and distention 
on motor axons associated with aging.  Additionally, post synaptic endplates reduce in size, 
length, number, and density (Jang and Van Remmen 2011).  Oxidative stress is thought to play a 
large role in the previously described degeneration of the NMJ.  Specifically, the homozygous 
deletion of Sod1 (CuZnSOD) in mice led to accelerated changes in the NMJ compared to those 
observed with aging (Jang, Lustgarten et al. 2010).  As a result, muscle contractile force is 
diminished in these Sod1knockout mice (Jang, Lustgarten et al. 2010).  However, there is also 
evidence that neural dysfunction is not a major contributing factor in sarcopenia.  As mentioned 
previously, when motor nerves of elderly individuals are electrically stimulated during voluntary 
maximal contraction no additional torque is produced (Vandervoort and McComas 1986).  Thus, 
in humans, it appears that declines in strength observed with aging have more to do with 
muscle atrophy rather than the inability to stimulate motor neurons. 
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Sarcopenia also changes muscle morphology.  Between the ages of 20  and 80 years, 
there is approximately a 50% reduction in total fiber number, with an accelerated decline after 
50 years of age (Lexell, Taylor et al. 1988).  The use of ATPase staining is able to analyze changes 
in muscle fiber types with aging.   It has been demonstrated that Type II fibers show a greater 
degree of atrophy than Type I fibers with aging, with an associated decrease in the mRNA 
content of MHC 2a and MHC 2x with age (Balagopal, Schimke et al. 2001).  Type II fibers have 
the greatest propensity for growth and produce more force when contracting than Type I fibers. 
Therefore, Type II fiber atrophy arguably has more negative implications than Type 1 fiber 
atrophy on mobility in the aging population.  Additionally, it’s been shown that as individuals 
age and experience Type II fiber atrophy there is a shift in proportion to more aerobic and 
oxidative myosin light chain (MLC) fiber types, with myosin heavy chain II (MLC II) isoforms 
increasing substantially (Klitgaard, Mantoni et al. 1990; Gannon J 2009). Sedentary elderly 
individuals show greater amounts of myosin heavy chain type I (MHC I)  and myosin light chain II 
fibers (MLC II) than younger individuals, which may be induced through compensation of Type II 
fiber atrophy (Klitgaard, Mantoni et al. 1990). 
Section 6.3: Mitochondrial Dysfunction and Oxidative Stress 
Mitochondrial dysfunction and oxidative stress may contribute to the progression of 
sarcopenia. The free-radical theory of aging suggests that age-related increases in mutagenic 
oxygen radicals lead to cellular damage and ultimately cellular senescence (Harman 1956). 
These free radicals are primarily produced in the mitochondria via oxidative phosphorylation, 
and are termed reactive oxygen species (ROS).  The increase in ROS is responsible for damage to 
mitochondrial DNA (mtDNA), leading to electron transport chain (ETC) protein defects 
(Greenlund LJ 2003; Johnston, De Lisio et al. 2008).  
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Disturbances within the mitochondria may mediate cellular apoptosis via the activation 
of caspase family of proteases (Green and Reed 1998).  In aging rats it has been shown that 
mtDNA copy numbers in skeletal, but not cardiac muscle, reduce with the aging process 
(Barazzoni, Short et al. 2000).  This decrease in skeletal muscle mtDNA suggests that skeletal 
muscle mtDNA seems to be less protected from degradation during the aging process or disuse.  
Oxidative stress is known to contribute to protein breakdown. Increases in ROS activate 
nuclear factor-kB (NF-kB). NF-kB is a transcription factor that up-regulates catabolic 
inflammatory cytokines such as interleukin 6 (IL-6), interleukin 1β (IL-1β), and tumor necrosis 
factor-α (TNF-α).  NF-kB tends to be elevated in elderly individuals contributing to sarcopenia 
(Bruunsgaard and Pedersen 2003), with elderly males having nearly a fourfold higher level of NF-
kβ in their myofibers than younger males (Cuthbertson, Smith et al. 2004).  More research still 
needs to be done to elucidate mitochondrial changes during aging, and their effects on the 
progression of sarcopenia.  Even though oxidative stress is a known contributor to protein 
breakdown, it has been observed that MPB does not increase during the aging process (Volpi, 
Sheffield-Moore et al. 2001).  Therefore, it appears that the decreases in LBM observed with 
aging are more so a result of decreases in MPS. 
Section 6.4: Behavioral Factors 
There are a number of behavioral factors that contribute to wasting, such as reduced 
physical activity, as well as reduced energy intake.  In the United States, the recommended daily 
amount of physical activity is 30+ minutes of moderate physical activity 5 days per week. 
According to the 2009 Behavioral Risk Factor Surveillance System, 61% of individuals aged 18-24 
get the recommended amount of daily physical activity, whereas only 40% of individuals over 
the age of 65 achieve the recommended amount (CDC 2009).  Age associated muscle weakness, 
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increased fatigability, and endurance losses all contribute to the observed age-related decreases 
in physical activity (Greenlund LJ 2003).  Decreases in endurance capacity are even observed in 
long-term (8 years) endurance trained older individuals, as evidenced by a 5.5% decrease in 
VO2max per decade.  However, those who were not endurance trained over 8 years experienced 
a 12% decline in VO2max per decade (Rogers, Hagberg et al. 1990).  The increased decline in 
VO2max in non-endurance trained individuals provides evidence that endurance exercise can 
attenuate the declining rate in VO2max as individuals age. Since resistance (Chesley, MacDougall 
et al. 1992; Biolo, Maggi et al. 1995) and endurance exercise (Sheffield-Moore, Yeckel et al. 
2004) can also increase MPS, incorporating and maintaining an exercise regime could help 
prevent the losses in LBM.  
It is common for older individuals to consume fewer calories than their younger 
counterparts.  Although many older individuals have decreased physical activity, many older 
individuals are still in negative energy balance.  This “anorexia of aging” is a common occurrence 
in the older population, and has a number of contributing factors.  Increases in gastrointestinal 
satiety signals such as the hormone cholecystokinin (CCK) are observed with age (MacIntosh, 
Andrews et al. 1999), limiting the neural drive to consume additional calories.  Additionally, age 
related decreases in taste, flavor, and palatability play a role in the decreased food intake 
(Morley 2001). Regardless of mechanism, negative energy balance increases AMPK, thus 
suppressing mTOR and MPS.  The inhibition of mTOR and MPS can lead to the decreases in LBM 






Section 7: Interventions 
Although losses of LBM are inevitable throughout the aging process, there are 
behavioral modifications that can attenuate this wasting.  Both exercise and proper nutritional 
practices seem to be promising strategies for preventing wasting. 
Section 7.1: Exercise 
 Resistance and aerobic exercise can lead to a positive muscle protein balance.  However, 
exercise’s effects on WBPT are still unclear. Carraro et al. failed to demonstrate an effect of 
aerobic exercise (4 hrs @ 40% VO2max) on WBPT both during and after the exercise bout 
(Carraro, Hartl et al. 1990). However, others have shown that aerobic exercise (3 hrs @75 
%VO2max) increases whole body protein synthesis following exercise, with WBPB not differing 
from values at rest (Devlin, Brodsky et al. 1990).  Although there is mixed evidence regarding 
aerobic exercise’s acute effects on WBPT, long-term aerobic exercise has been shown to 
increase basal WBPT (Lamont, Patel et al. 1990), while decreasing leucine oxidation at rest 
(Gaine, Viesselman et al. 2005). This indicates improved protein utilization as a result of 
exercise.  
Aerobic exercise and its magnitude of effect on NBAL appears to be dependent on 
energy balance.  When maintaining energy balance, aerobic exercise increases NBAL over time 
(Todd, Butterfield et al. 1984; Gaine, Viesselman et al. 2005).  However, the increases in NBAL 
observed from aerobic exercise are decreased when individuals are in hypocaloric state (Todd, 
Butterfield et al. 1984).  Additionally, if protein intake is adequate, a caloric deficit created by 
increased physical activity results in a greater NBAL than if the deficit is created through diet 
alone (Todd, Butterfield et al. 1984). 
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In rodents, acute aerobic exercise not only inhibits MPS during the bout of exercise 
(Dohm, Kasperek et al. 1980; Davis and Karl 1986), but also increases MPB (Dohm, Kasperek et 
al. 1980)  as a result of increased amino acid utilization during exercise in order to meet the 
increased energy demand. The magnitude of decrease in MPS during aerobic exercise is 
positively correlated with the exercise intensity (Balon, Zorzano et al. 1990), and duration 
(Dohm, Kasperek et al. 1980).  Additionally, it does not appear that prior endurance training 
attenuates the decrease in MPS observed with acute aerobic exercise (Davis and Karl 1986).  The 
decrease in MPS and increase in MPB,  results in an acute negative net protein balance during 
the exercise bout (Norton LE 2006).   
 Despite decreases in MPS and increases in MPB during exercise, physical activity has 
been shown to lead to the maintenance or increase in skeletal muscle, as well as an increased 
NBAL.  This indicates a compensatory response within the post-exercise recovery period to 
increase MPS and/or decrease MPB.   It is well known that MPS (Chesley, MacDougall et al. 
1992; Biolo, Maggi et al. 1995) and mixed muscle fractional synthetic rate (FSR) (Phillips, Tipton 
et al. 1997) increase following resistance exercise, with elevations in MPS observed for up to 48 
hr (Phillips, Tipton et al. 1997) or 72 hr (Miller, Olesen et al. 2005) following the resistance bout.  
Additionally, MPB (Biolo, Maggi et al. 1995) and fractional breakdown rate (FBR) (Phillips, Tipton 
et al. 1997) increase following resistance exercise, however MPB is elevated to a lesser extent 
than MPS (Biolo, Maggi et al. 1995).  Muscle protein balance therefore improves (Biolo, Maggi et 
al. 1995; Phillips, Tipton et al. 1997), but does not reach a positive value (Biolo, Maggi et al. 
1995).  Additionally, there is evidence that chronic resistance training can increase resting 
myofibrillar FSR.  After 10 weeks of chronic resistance training in the fed state, resting 
myofibrillar FSR increased 37% over prior resting conditions (Wilkinson, Phillips et al. 2008).  
Additionally,  4 months of aerobic (bicycle) training (up to 45 min at 80% max heart rate, 3-4 
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days/week) has been shown to increase steady-state mixed MPS 22% from baseline (Short, 
Vittone et al. 2004). 
Regarding aerobic exercise, MPS increases following aerobic exercise at 40% VO2Max 
(Sheffield-Moore, Yeckel et al. 2004) and at 72 ± 1% VO2Max (Harber, Konopka et al. 2010). 
Additionally, increases in MPS following aerobic exercise have been observed in both the fasted 
and fed state (Harber, Konopka et al. 2010).  However, there is evidence that increases in MPS 
resulting from aerobic exercise is balanced by equivalent increases in MPB (Sheffield-Moore, 
Yeckel et al. 2004).  
Additional research has also been done comparing the response of both young and old 
populations to resistance and aerobic training programs.  The fractional rate of MPS in the 
quadriceps of elderly individuals is lower than younger individuals prior to undergoing a 
resistance training program, but 2 weeks of daily resistance exercise was shown to increase FSR 
of muscle to the same extent seen in the younger individuals measured following the last bout 
of resistance exercise (Yarasheski, Zachwieja et al. 1993).  Additionally, in the elderly group, 
there was no observed increase in MPB after 2 weeks of training, as measured following the last 
bout of resistance exercise (Yarasheski, Zachwieja et al. 1993). There is mixed evidence on 
whether elderly individuals experience a similar anabolic response to exercise as their younger 
counterparts.  In one study, after an acute bout of moderate intensity aerobic exercise (40% 
VO2max), mixed muscle FSR was not statistically elevated at time points measured beyond 10 
minutes post-exercise in untrained older men (Sheffield-Moore, Yeckel et al. 2004).  However, 
mixed muscle FSR was still elevated at 60 minutes post exercise in younger untrained men 
following the same protocol (Sheffield-Moore, Yeckel et al. 2004).  Another study found no 
differences in mixed MPS between young and old men following 4 months of aerobic exercise 
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(up to 45 min @ 85% max heart rate for 3-4 days/week) (Short, Vittone et al. 2004).  
Additionally, it has been shown that prolonged aerobic exercise can increase myofiber size in 
elderly women (Harber, Konopka et al. 2009), thus providing evidence of the benefits of aerobic 
exercise increasing LBM in elderly individuals. 
 The benefits of aerobic exercise extend beyond its direct impact on protein turnover.   
As individuals age, insulin’s ability to vasodilate decrease (Meneilly, Elliot et al. 1995).  It is 
thought that insulin’s blunted ability to stimulate MPS in older individuals is largely due to its 
reduced ability to induce vasodilation (Fujita S 2007). However, it’s been shown in older subjects 
that a single bout of moderate aerobic exercise can improve endothelial function, by enhancing 
the vasodilating properties of infused insulin and promote MPS through insulin’s action on 
phosphorylating Akt and mTOR/S6 kinase (Fujita S 2007). The control group who did not 
exercise experienced no increases in MPS via insulin infusion (Fujita S 2007).  
 Exercise has a number of benefits with regards to reducing the effects of wasting, 
serving as a stimulus that can lead to positive protein balance during the recovery period.  Since 
there is evidence that in isolation neither resistance nor aerobic training induces a positive 
protein balance, the hypertrophic response following exercise must be dependent on additional 
factors such as feeding.   
Section 7.2: Nutrition after exercise 
 In the absence of nutrient intake after exercise, net protein balance will remain negative 
(Biolo, Maggi et al. 1995). However, proper ingestion of amino acids with or without 
carbohydrate causes a shift towards increased protein balance in the post exercise period (Biolo, 
Tipton et al. 1997; Miller, Tipton et al. 2003; Borsheim, Aarsland et al. 2004). Although 
hyperinsulinemia at rest increases MPS, hyperinsulinemia post exercise provides no further 
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increases in MPS (Biolo, Williams et al. 1999).  However, hyperinsulinemia’s ability to decrease 
MPB is increased following exercise compared to rest (Biolo, Williams et al. 1999).  Insulin’s 
inability to stimulate MPS following exercise provides evidence to the importance of amino acids 
during the post exercise period to further increase MPS to create a positive protein balance. 
 It has been shown that in fasting humans at rest, infusion of amino acids increases MPS 
and NBAL, with no effects on MPB (Biolo, Tipton et al. 1997).  However, the same amino acid 
infusion after a bout of resistance exercise results in greater levels of MPS, which suggests an 
additive effect of the exercise and the amino acids (Biolo, Tipton et al. 1997).  An additional line 
of thought is that exercise serves as a stressor, and that EAA ingestion provides the nutritional 
substrates necessary to induce adaptation to this stress (Miller 2007).  By consuming amino 
acids with carbohydrates post exercise, net protein balance can be increased to levels greater 
than if an amino acids or carbohydrate were ingestion alone (Miller, Tipton et al. 2003; 
Borsheim, Aarsland et al. 2004).  Mechanistically, the acute increases in MPS that occur after 
post exercise feeding occur at the level of translation initiation, with the availability of eIF4E for 
48S ribosomal complex formation increasing after a complete meal feeding post exercise 
(Gautsch, Anthony et al. 1998). 
There is relatively limited data in the area of post aerobic exercise nutrition in the 
elderly population.  When consumed post aerobic exercise, it has been shown that protein 
combined with carbohydrate (40g carbohydrate, 20g whey) leads to increases in WBPT in the 
elderly above that observed with an isoenergetic amount of carbohydrate (60g carbohydrate) 





Section 7.3: Nutrient Timing 
 The timing of amino acid and carbohydrate ingestion has an influence on the degree of 
increase in protein balance.  In resistance trained older male subjects the consumption of a 
post-workout protein beverage (10g protein, 7g carbohydrate, 3 g fat) immediately after 
resistance exercise resulted in greater gains in muscular hypertrophy and isokinetic strength 
after 12 weeks, than if the beverage was consumed 2 hrs following resistance exercise (Esmarck, 
Andersen et al. 2001).  In another study either 6g of EAA with 35g of sucrose or a placebo was 
consumed either 1 hour or 3 hours after a bout of resistance training (Rasmussen, Tipton et al. 
2000).  Although consumption of the beverage at both time points resulted in greater MPS than 
the placebo, there was no statistical difference in net protein balance when the drink was 
consumed 1h or 3h post exercise (Rasmussen, Tipton et al. 2000). MPB was also unchanged by 
the consumption of the drink vs. the placebo, indicating that the increase in anabolism was due 
to increased MPS (Rasmussen, Tipton et al. 2000). With regards to aerobic exercise, the 
consumption of an oral supplement (10g protein, 8g carbohydrate, 3g fat) consumed 
immediately after exercise resulted in greater increases in MPS than if consumed 3 hours after 
exercise (Levenhagen, Gresham et al. 2001).  However, a longer duration study found that post 
aerobic exercise protein ingestion did not lead to increases in mixed MPS over the course of 6 
weeks, providing evidence that the acute increases in MPS occurring after post exercise protein 
feeding do not persist long-term (Robinson, Turner et al. 2011).  
 In a study similar to ours, young female athletes following two seven-day trials of 
increased training volume, the post exercise consumption of a mixed-meal beverage led to an 
increased trend (p=.06), albeit insignificant, towards a more positive NBAL than if consumed 
earlier in the day.  Similar to our study, the two trials were isocaloric and isonitrogenous, with 
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only the timing of the mixed-meal beverage differing between trials (Roy, Luttmer et al. 2002). 
As mentioned previously, our lab has also shown that the consumption of chocolate milk 
immediately following moderate aerobic exercise (55% VO2max) in older adults in energy 
balance, leads to greater NBAL than if it is consumed earlier in the day.  The increase in NBAL is 
especially significant due to the fact that both trials were isocaloric and isonitrogenous, with the 
only difference being the timing of the milk intake (Jordan, Melanson et al. 2010).  
 
Section 8: Leucine 
 The composition of amino acids ingested following exercise has a direct impact on 
increasing protein synthesis thus creating a shift towards a positive protein balance.  EAAs are 
primarily responsible for stimulating MPS in the elderly (Volpi, Kobayashi et al. 2003), while non 
essential AA are not sufficient in initiating MPS in the elderly (Volpi, Kobayashi et al. 2003), or in 
young populations (Tipton, Gurkin et al. 1999).  Thus, choosing a protein source rich in EAA, 
particularly leucine, is important for increasing MPS. 
BCAAs, particularly leucine, are known regulators of MPS and translation initiation 
(Kimball and Jefferson 2001), and plays an important role in the protein synthetic response from 
feeding.  Leucine itself, in the absence of other amino acids, is capable of initiating mRNA 
translation, exerting its effects on protein synthesis through the mTOR signaling pathway, 
including S6K, eIFs, and 4E-BP1 (Anthony, Lang et al. 2002; Crozier, Kimball et al. 2005). 
Additionally, leucine has the ability to stimulate MPS in a manner independent of mTOR 
activation.  This mTOR independent stimulation of MPS occurs via the direct activation and 
phosphorylation of eIF4G, resulting in the ability of eIF4E to join with eIF4G to initiate MPS 
(Bolster, Vary et al. 2004). 
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Research has also examined the leucine content in meals in regards to plasma leucine 
and protein synthesis.  Meals that are low in protein (10g/meal) with low leucine are inferior in 
increasing plasma leucine to meals higher in protein (30g/meal) with higher leucine levels 
(Layman DK 2003).  Additionally, the quantity of leucine in isonitrogenous meals will directly 
affect the peak activation of protein synthesis, however it does not affect the duration (Norton 
LE 2009).  Whey, a rich source of leucine, is able to stimulate MPS to a greater extent than an 
isonitrogenous amount of wheat protein, which has a lower comparative leucine content 
(Norton LE 2009).  Additionally, consumption of whey hydrolysate both at rest and after a bout 
of acute resistance exercise increases blood leucine and MPS to a greater degree than an 
isonitrogenous amount of micellar casein or soy protein isolate (Tang, Moore et al. 2009). 
Leucine has therefore been proposed to be a key component of a meal with regards to 
increasing protein synthesis (Layman DK 2003).  
 Following an acute bout of endurance exercise, plasma leucine concentrations decrease 
(Paul, Rokusek et al. 1996).  Post-exercise leucine ingestion has therefore been examined as an 
aid to the recovery process.  Following exhaustive aerobic exercise in rats, the ingestion of a 
glucose and sucrose electrolyte beverage increases blood glucose, glycogen content, and insulin 
concentrations, but has no effect on increasing MPS (Gautsch, Anthony et al. 1998).  However, 
post exercise ingestion of leucine alone (Anthony, Anthony et al. 1999) or a complete meal with 
protein (Gautsch, Anthony et al. 1998) increases MPS, indicating the importance of protein (and 
leucine) during the recovery period.  As mentioned previously, consumption of whey 
hydrolysate (a rich source of leucine) results in greater MPS than micellar casein and soy protein 
isolate when consumed following a bout of resistance training (Tang, Moore et al. 2009). 
Additionally, leucine in addition to protein and carbohydrate has been shown to increase whole 
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body protein balance to a larger extent than carbohydrate with protein, or carbohydrate alone 
when consumed post exercise (Koopman, Wagenmakers et al. 2005).  
Section 9: Milk as a postexercise beverage 
While many studies have used customized blends of protein and carbohydrate 
beverages when studying the effects of protein and/or carbohydrate after exercise, relatively 
few studies have used a naturally occurring food source.  An economical and easily accessible 
source of essential amino acids (particularly leucine) and carbohydrates is in the form of milk. 
Both fat free and whole milk have been shown to stimulate MPS after resistance exercise (Elliot, 
Cree et al. 2006). Skim milk has also been shown to result in greater protein balance and 
fractional synthesis rates over 3 h than an isocaloric, isonitrogenous soy-protein beverage when 
consumed after resistance training (Wilkinson SB 2007).  As mentioned previously, our lab has 
shown that consumption of chocolate milk immediately following 1 hour of moderate intensity 
aerobic exercise, can lead to greater increases in NBAL in older individuals in energy balance 
than if  the milk is consumed earlier in the day (Jordan, Melanson et al. 2010). 
There are dietary sources of both “fast” and “slow” acting proteins.  Both whey and 
casein are milk fractions, with fluid bovine milk containing approximately 80% casein and 20% 
whey by mass (Wilkinson SB 2007). Whey, considered a “fast” protein, digests rapidly and 
provides a rapid, although short lived rise in plasma AAs (Boirie, Dangin et al. 1997).  Casein, 
considered a “slow” protein, provides a more moderate but prolonged rise in plasma AAs. 
Casein’s effects are thought to be due to delayed gastric emptying (Boirie, Dangin et al. 1997). 
Additionally, casein has been shown to reduce protein breakdown, whereas whey actually 
increases leucine oxidation (Boirie, Dangin et al. 1997). Since whey is more effective at 
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stimulating rapid increases in plasma AAs and protein synthesis, combining it with casein to 
reduce protein breakdown is a viable strategy to increase the anabolic environment.    
Section 10: Conclusions 
 Wasting has a number of factors influencing the loss of muscle mass and strength as 
individuals age.  However, both exercise and nutrition are within one’s own control and can be 
manipulated to elicit a greater NBAL over time.  Combining regular exercise with balanced daily 
caloric intake and proper post workout nutrition can attenuate the progression or onset of 
wasting.  Our lab previously showed that in older individuals in energy balance, consumption of 
protein and carbohydrates (chocolate milk) immediately following moderate aerobic exercise at 
55% VO2max led to greater 3-day mean NBAL than if consumed earlier in the day.  Because 
increased energy intake leads to increases in NBAL (Munro 1951; Butterfield and Calloway 
1984), we wish to further investigate the impact of the timing of protein intake on NBAL in 




METHODS AND PROCEDURES 
 
Overview 
 The present study compared NBAL in older subjects in positive energy balance with 
chocolate milk consumption immediately following moderate aerobic exercise compared 
chocolate milk consumed earlier in the day. Two, three-day periods were used for each 
intervention and were isocaloric and isonitrogenous to one another.  The only difference within 
the phases was the timing of the milk protein intake.  There were four distinct periods within 
the duration of the study for each participant: the pre-experimental testing, a 7-day lead in diet, 
the 6-day experimental intervention consisting of 2, 3-day phases, and post testing (Figure 3.1).  
The study protocol was approved by the Colorado State University Institutional Review Board 
and the Colorado Multiple Institutional Review Board for human participants research.    
Figure 3.1 Experimental timeline 
 
Pre-testing   Lead-in                           Experimental   Post-testing 
Day 1: GXT, diet log 
collection                                 
Day 2: RMR, DEXA               
Day 3: VO2max                             
Day 4: steady-state 
VO2 
2-3 wks break 




Controlled diet, daily 
weight measurement, 2 
days with activity 
monitor 
Controlled diet, 1-hr daily 
exercise followed by test 
beverage, 24-hr urinary 
collection, daily weight 
measurement, activity 
monitor, 2 days in Cal Room  
















 13 consecutive days 
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The pre-testing period allowed for planning of lead-in and controlled experimental diets. The 
lead-in diet allowed subjects to adapt to the level of protein intake they would be exposed to 
during the experimental portion of the study.  This adaptation period may be necessary since 
protein kinetics can change with acute changes in protein intake (Rand, Young et al. 1976), 
although this is currently debated (Yarasheski, Castaneda-Sceppa et al. 2011).  Regardless of 
whether a lead-in period is necessary for adaptation to changes in protein intake, we took a 
conservative approach to insure our subjects did not have changes in NBAL due solely to acute 
changes in protein intake.  
 During the experimental portion of the study, subjects underwent a 6-day inpatient stay 
at the University of Colorado Denver Clinical and Translational Research Center (CTRC).  Each 
subject completed 2, 3-day trials in a randomized cross-over design (CHO and PRO+CHO).  Days 
1 and 6 of the patient’s stay were spent in the whole room calorimeter to confirm positive 
energy balance (Figure 3.2). 
Figure 3.2 Experimental in-patient period 
 
 The subjects stayed in an in-patient hospital room at the CTRC for days 2-5, where they 
were permitted to leave for 30 minutes twice a day.  Breakfast, lunch, and dinner were all 
served at the same times every day.  From 4:30-5:30 pm each day, subjects performed one hour 
of cycling exercise @ 55% VO2 max.  Immediately following the exercise, subjects consumed the 







respective post-exercise beverage.  During the PRO+CHO phase, subjects consumed a chocolate 
milk beverage immediately after exercise (5:30 pm), with a carbohydrate beverage consumed 
earlier in the day (10:00 am).  During the CHO phase, subjects consumed the carbohydrate 
beverage immediately after exercise (5:30 pm), with the chocolate milk beverage consumed 
earlier in the day (10:00 am) in the CHO phase.  Total energy, macronutrients, and food were 
identical for both conditions.  The only difference between phases was the timing of the protein- 
containing beverage (Figure 3.3). 
 Figure 3.3 Timing of meals and consumption of beverages during in-patient stay 
 
Participants 
 Six male (n=2) and female (n=4) subjects between 55 and 75 years old were recruited  
from the Fort Collins and Loveland, Colorado area.  Individuals were required to be inactive, 





































included: obesity (BMI > 30), any orthopedic injury that impeded their ability to exercise, any 
conditions that affected food digestion, any thyroid condition (TSH <0.05 mu/mL or TSH>5.0 
mu/mL), bleeding disorders, or any current illness and/or infection.  Due to finances, we were 
limited to six subjects.  See Table 3.1 for subject characteristics. 
Table 3.1 Subject Characteristics 
 Male (n=2) Female (n=4)  All subjects (n=6) 
 Mean ±SEM Mean ±SEM Mean ±SEM 
Age 62.50 ± 5.50  
 
66 ± 2.04 64.83 ± 2.06 
Height (cm) 175.26 ± 2.54 
 
160.02 ± 1.37 165.10 ± 3.39 
Weight (kg) 84.68 ± 2.95 
 
59.66 ± 3.16 68.00 ± 5.69 
BMI (kg/m2) 27.61 ± 1.76 
 
23.34 ± 1.47 24.76 ± 1.37 
Body fat (%) 24.70 ± 1.30 
 
37.93 ± 4.21 33.52 ± 3.87 
VO2max (ml·kg
-1·min-1) 32.30 ± .80 
 
22.93 ± 1.88 26.05 ± 2.32 
 
Screening 
At the initial visit, subjects read and signed an informed consent, HIPAA-B Approval 
form, and a medical and exercise history questionnaires (Appendices A, B, and C).  In addition, 
online food preference and food allergy questionnaires from the CTRC were completed and 
three-day diet logs were given to the subjects who were instructed to maintain normal eating 
habits and record all foods and beverages consumed for 2 week days and 1 weekend day.  
Subjects returned their completed three-day diet logs at the first pre-testing appointment.  The 
diet logs were entered into NutritionistPro software (Axxya Systems, Stafford, TX) in order to 
analyze and determine habitual daily energy and macronutrient intakes.  Subjects also 
completed a blood draw at Poudre Valley Hospital prior to the initial pre-testing appointment, 
46 
 
which was analyzed for blood lipid profile, and normal thyroid stimulating hormone 
concentrations.  
Pre-Testing 
 Over the course of four separate days, subjects completed a series of pre-tests at the 
HPCRL in the Department of Health and Exercise Science at Colorado State University.  On the 
initial visit, subjects completed a treadmill graded exercise test (GXT).  The test began with 
subjects walking at 3.3 miles per hour (mph) at 0% grade.  The treadmill speed remained at 3.3 
mph for the duration of the test but the grade increased 2% after the first, and 1% every minute 
thereafter.  Data collected during the test included: heart rate, rating of perceived exertion 
(RPE), blood pressure, and an electrocardiograph (EKG), all of which were recorded every three 
minutes.  The test was terminated when subjects reached 85-100% of their predicted maximum 
heart rate (220-age) or when the subjects were too exhausted to continue.  The GXT was 
supervised by an on-site cardiologist who excluded subjects if the test indicated an ischemic or 
hypertensive response to the exercise. 
 Subjects returned to the HPCRL on a second day, following an overnight fast.  Resting 
metabolic rate (RMR) was measured (Parvomedics TrueOne 2400, Sandy, UT) in order to 
determine the subject’s 24-hour resting caloric expenditure.  During the test, subjects were 
instructed to rest in the supine position with the lights dimmed and all expired gases were 
collected.  Subjects were asked to refrain from sleeping during the testing procedure.  The flow 
rate was manually adjusted throughout testing to maintain FECO2 levels between 0.9-1.0%.  The 
testing procedure lasted a total of 45 minutes.  The first 15 minutes of the test was used to 
achieve the appropriate flow rate and to allow subjects to become familiarized and comfortable 
with the experimental conditions.  The final 30 minutes of data was used to measure the 
47 
 
subject’s RMR using the Weir equation (Weir 1949).  Reported values for daily energy 
expenditure were averaged with measurements outside ±2 standard deviations being omitted.  
Following the RMR test, subjects were administered a dual-energy X-ray absorptiometry (DEXA) 
scan (QDR 4500W, Hologic, Inc., Bedford MA) in order to determine body composition and bone 
mineral density. 
 On the third day of testing subjects underwent an incremental exercise test on a cycle 
ergometer (Monark Excalibur, Groningen, The Netherlands) with indirect calorimetry 
(ParvomedicsTrueOne 2400, Sandy, UT) to determine the subject’s VO2max.  Subjects pedaled at 
50 Watts for the first minute with subsequent 20 (female) or 30 (male) Watt increases every two 
minutes.  During the test, subjects maintained a pedal rate between 70-90 rpm.  The test was 
terminated once the following criteria were met: subjects reached volitional exhaustion, heart 
rate was within 10 beats of age predicted maximum heart rate, respiratory exchange ratio (RER) 
was greater than 1.1, and when VO2 reached a plateau (Brooks GA 2005).  Following the 
determination of subject’s VO2max, 55% of each subject’s VO2max was calculated and recorded.  
Equation 3.1 (ACSM 2010)was utilized in estimating the cycle ergometer rate that would 
correspond to a steady-state exercise intensity at 55% of VO2max. 
Equation 3.1  ACSM leg cycle ergometry equation 
VO2 (ml∙kg
-1∙min-1) = 1.8 (work rate)/ (BM)* + resting VO2 (3.5 ml∙kg
-1∙min-1) + unloaded 
cycling  (3.5 ml∙kg-1∙min-1) 
*work rate=kg∙m∙min-1 and BM=body mass (kg) 
 Subjects returned to the HPCRL on a third day for a submaximal steady-state cycling 
test.  Subjects began cycling at their calculated workload of 55% VO2max (from equation 3.1).  
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Once VO2 stabilized subjects continued cycling for an additional 30 minutes. Using indirect 
calorimetry, exercise energy expenditure was determined by averaging the energy expenditure 
from the final 30 minutes of cycling. The calculated energy expenditure from the 30 minutes of 
cycling was used to calculate the subject’s energy expenditure for the one hour of cycling that 
would occur daily during the inpatient period. 
7-day lead in diet period 
Two to three weeks following the pretesting period, subjects completed a controlled, 7-
day lead-in diet immediately prior to their inpatient stay and the intervention/experimental 
period.  The purpose of the lead-in diet was to habituate subjects to the protein intake of the 
inpatient intervention (1.2g/kg bw).  Exposure to this protein intake ruled out the possibility that 
NBAL data during the inpatient intervention period was due to an adaptation to a new level of 
protein ingestion.  
Both the lead-in and in-patient study diets were constructed using Pronutra software 
(Viocare, Inc., Princeton, NJ) by a licensed dietician.  In addition to the 1.2 g/kg bw of protein, 
30% of caloric intake was in the form of dietary fat, with the remaining balance coming from 
carbohydrate.  During the lead-in period subjects were kept in energy balance.  Lead-in diet 
energy intake was calculated by using their calculated RMR multiplied by an activity factor of 
1.5, as in our previous study (Jordan, Melanson et al. 2010). 
 During the lead-in diet subjects were instructed to arrive every morning to the Colorado 
State University Nutrition Center.  Food for the day was prepared with breakfast being 
consumed in front of study staff.  Food for the rest of day was sent home with the subjects in a 
cooler with instructions to eat only the contents within the cooler.  Subjects returned the 
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following day for the next days’ worth of food.  Subjects were instructed to undergo their typical 
daily activities throughout the duration of the 7-day lead-in period.  
 On the evening of the 7th day of the lead-in period, subjects were admitted to the 
University of Colorado-Denver CTRC, where they were fed dinner.  The following day started the 
6-day in-patient intervention/experimental period of the study. 
 
6-day experimental intervention 
 The experimental intervention involved a 6-day stay at the University of Colorado-
Denver CTRC, with subjects following an inpatient diet and 24-hour urine collection.  Both the 
first and last day of the inpatient stay were spent in a 12’ x 12’ whole room calorimeter, while 
days 2-5 were spent in a regular inpatient room at the CTRC.  During days 2-5, subjects were 
permitted to leave their room for 30 minutes, twice a day.  Subjects were only allowed to eat 
only what was provided to them and were instructed to refrain from exercise outside of the 1 hr 
of moderate intensity cycling that occurred each day.  Subjects were allowed to consume water 
ad libitum, but were allowed to request additional non-caloric, non-caffeinated beverages as 
well. Subjects were weighed in their hospital gowns at the same time, on the same scale each 
morning.  
 Subjects each completed two 3-day trials in a randomized crossover design. Every day at 
4:30 pm, subjects participated in 1 hr of cycling exercise at 55% VO2max.  All exercise was 
performed on a Lode Corival bicycle ergometer (Lode, Groningen, The Netherlands).  Subjects 
recorded their heart rate every 15 minutes during exercise using a heart rate monitor (Polar FS1, 
Lake Success, NY).  The exercise was intended to be of approximately the same intensity as a 
brisk walk, and was tolerated well by all subjects. 
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 Following the daily exercise bout, a post-exercise beverage was immediately consumed 
at 5:30 pm.  During the PRO + CHO phase, the beverage consumed immediately after exercise 
was a 248kcal chocolate milk drink which contained 15.3 g PRO, 43.6 g CHO, and 1.3 g FAT (330g 
skim milk, 4 g whey protein, and 42 g chocolate syrup).  During the CHO phase, the beverage 
consumed immediately after exercise was a 247kcal Kool-Aid beverage which contained 0 g 
PRO, 63.51 g CHO, .06 g FAT. During each respective phase, the opposing drink (Kool-Aid for the 
PRO + CHO phase, Chocolate milk drink for CHO phase) was consumed as a snack at 10:00 am. 
The order in which subjects completed each phase was randomized. 
 Within each of the 3-day trials the patient’s diets were reproduced and identical in 
terms of caloric intake, macronutrient profile, and foods consumed.  Specifically, the diet plans 
for day 1, 2, and 3 were repeated on days 6, 4, and 5, respectively (Reference Table 3.2 on next 
page for sample in-patient diet plan).  The only difference between phases was the timing of the 
intake of the chocolate milk drink.  Similar to the lead-in diet, the in-patient diet plan was 
composed of 1.2g of protein/kg bw, 30% of calories from dietary fat, and the balance as 
carbohydrate.  Both the lead-in and inpatient diets corresponded with the USDA’s acceptable 











 Table 3.2. Sample inpatient diet plan 
  
Since the goal was to have subjects in 15% caloric excess, estimated daily energy 
expenditure (EE) was calculated prior to the in-patient diet.  In the original energy balance study 
the subject’s RMR was multiplied by an activity factor of 1.35 for the calorimeter days, and by 
1.45 for the non-calorimeter days in order account for additional activity outside of the 
calorimeter room (Melanson, unpublished data).  However, it was determined that subject’s 
actual energy balance was higher than estimated in the energy balance study.  Therefore, for 
this study the subjects RMR was multiplied by 1.30 for the calorimeter days, and by 1.40 for the 
non-calorimeter days. Then, steady state VO2 data was used to estimate energy expenditure 
(EE) during exercise with an additional 20% factored in for excessive post exercise oxygen 




Diet: Breakfast (B), Snacks (S), Lunch (L), Dinner (D) 
1 (CHO)     Cal 
room 
1896 B-oatmeal    S- chocolate milk   L-salad  S- Kool-Aid  D-spaghetti                                                                                                                                                                                                                                                  
2 (CHO) 1988 B-toast        S- chocolate milk      L-soup       S- Kool-Aid      D-stir-fry                                                                                                                                                                      
3 (CHO)      1972 B-eggs   S-chocolate milk  L-sandwich S- Kool-Aid  D-steak/potato                                                                                                                                                                                                                                                         
4(PRO+CHO) 1988 B-toast        S- Kool-Aid          L-soup      S- chocolate milk   D-stir fry                                                                                                                                                                                                                                                                                                                                                             
5(PRO+CHO) 1972 B-eggs  S- Kool-Aid  L-sandwich  S- chocolate milk D-steak/potato                                                                                                                                                                                                                                                                                                                                                           
6(PRO+CHO) 
Cal room 
1896 B-oatmeal    S- Kool-Aid   L-salad   S- chocolate milk   D-spaghetti                                                                                                                                                                                                                                                         
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3.2 was used to predict total daily energy expenditure (TDEE) for calorimeter room and inpatient 
days.  
Equation 3.2 Estimation of TDEE 
EE= (Activity factor (variable)  x RMR) + (exercise EE + (.2 x exercise EE)) (Gersovitz, Motil 
et al. 1982). 
The calorimeter room was calibrated with ambient air (O2 = 20.93% and CO2=0.03%) and 
a known gas mixture (O2 =20.1% and CO2 =0.9%).  The dimensions of the room were 12’ x 12’, 
and contained a bed, sink, toilet, bicycle ergometer, computer, and television for subject use.  
Subjects entered the calorimeter room at 7:45 am on Days 1 and 6, and exited at 7:15 am on the 
following morning.  While in the calorimeter room, subjects were not permitted to nap or 
perform any exercise other than the one hour of cycling from 4:30-5:30 pm.  To prevent air from 
escaping the calorimeter room, all meals were passed through an air lock that could not be 
simultaneously opened from the outside or inside of the room.  Daily energy expenditure and 
substrate oxidation were calculated using the difference in the O2 and CO2 gas content that was 
entering and exiting the room.  To prevent air from escaping, all meals were passed through an 
air lock that could not be simultaneously opened from the inside and outside.  Daily energy 
expenditure and substrate oxidation were calculated by the difference in gas content that was 
entering and exiting the room.  Specifically, the difference in the incurrent and excurrent 
airstream’s gas content was determined by using a differential infrared carbon dioxide analyzer 
(ABB Advance Optima Uras 14 NDIR CO2 Analyzer; ABB, Zurich, Switzerland) as well as a 
differential paramagnetic oxygen analyzer (Siemens Oxymat 6E Oxygen Gas Analyzer; Siemens, 
Houston, TX).  All analyzed gas values were further corrected for relative humidity, barometric 
pressure, and temperature (Melanson, Ingebrigtsen et al. 2010).  Total energy expenditure and 
substrate oxidation were calculated by using oxygen consumption and respiratory quotient (RQ) 
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(Jequier, Acheson et al. 1987).  All measurements reported as one-minute averages in the data 
file. 
During the inpatient stay (including calorimeter days), subjects wore an accelerometer 
(Actigraph GT1M, Pensacola, FL), which was removed during sleep, showering, and exercise.  
Using the accelerometer data, energy expenditure from non-exercise daily activity was 
estimated.  The Freedson equation (Equation 3.3) was used to estimate EE for activity 
counts >1,952 per minute (Freedson, Melanson et al. 1998).  For activity counts ≤ 1,952 per 
minute, EE was estimated using the work energy theorem (Equation 3.4). 
Equation 3.3 Freedson equation  
Kcal/min = 0.00094*counts/minute + 0.1346*body mass (kg) – 7.37418 
Equation 3.4 Work-energy theorem  
Kcal/min = 0.0000191*counts/minute*body mass (kg)  
TDEE on calorimeter days was directly measured and non-calorimeter days was 
estimated by using Equation 3.5. 
Equation 3.5 TDEE on non calorimeter days 
TDEE= RMR + non-exercise EE (from accelerometer) + exercise EE (measured as average of 2 
days in calorimeter room) + dietary induced thermogenesis (measured as average of two days in 
calorimeter room) 
Energy balance for the inpatient period was determined using Equation 3.6, with energy intake 




Equation 3.6 Daily Energy Balance 
EB= caloric intake- TDEE. 
Daily physical activity level (PAL) was calculated using Equation 3.7, while non-exercise 
PAL was calculated using Equation 3.8. The value for exercise energy expenditure was multiplied 
by 1.2 to account for the additional energy expenditure resulting from post exercise oxygen 
consumption (EPOC) (Melanson, unpublished observations, (Jordan, Melanson et al. 2010)). 
Equation 3.7 Physical activity level (PAL) 
PAL=TDEE/RMR 
Equation 3.8 Non-exercise PAL. 
Non-exercise PAL = (TDEE - Exercise EE*1.2)/RMR 
Nitrogen Balance Data Collection 
 NBAL was determined through continuous 24 hr urine collection from subjects. Urine 
was analyzed for urinary N using the chemiluminescent technique.  Specifically, N was analyzed 
by using an Antek 7000 Elemental Nitrogen Analyzer (PAC, Houston, TX).   N intake was 
calculated as g of protein intake divided by 6.25, since 6.25 g of protein contains approximately 
1g of N.  Fecal N was estimated at 2g/day, while miscellaneous N loss was estimated at 5mg/kg 
bw (Calloway, Odell et al. 1971). NBAL was calculated using equation 3.8. 
Equation 3.8 Nitrogen Balance 
NBAL (g)= N intake (calculated via protein consumption) - (fecal N + urinary N(directly 
measured) + misc. N loss) 
Both 3 day trials of NBAL data were averaged to compare both the CHO, and the PRO + CHO 





 Following the inpatient intervention/experimental period, subjects reported back to 
Colorado State University for a final visit. This visit typically occurred within a week of 
completion of the inpatient stay. Subjects received a follow up DEXA scan, as well as the analysis 
of their 3-day food logs which they completed as part of the pre-testing procedures.  Lastly, the 
subjects were compensated for their participation. 
 
Statistical Analysis 
 All statistical analysis were performed using GraphPad Prism (version 4.00 for 
Macintosh, Graphpad Software, San Diego, California).  NBAL is the primary dependent variable 
in this study.  NBAL data, energy balance data, as well as pretest/posttest bodyweight and body 
fat data were analyzed using student’s paired t tests.  Any correlations between NBAL and 
energy balance, or NBAL and relative protein intake (g/kg bw) were determined using Pearson’s 
“r”.  One-way repeated measures ANOVA and multiple regressions analyzed all diet related 
variables within the free-living, lead-in diet, inpatient stay.  Differences that occurred within the 
diet related variables were determined via the Student Newman-Keuls post hoc test.  All 












Energy and macronutrient intake 
 The study diets followed USDA Nutritional guidelines and foods selected were typical for 
each subject.  Figure 4.1 depicts the average energy intake for subjects under the free-living, 
lead-in, and inpatient phases of the study.  Additionally, Figure 4.2 depicts the average 
macronutrient intakes for subjects under the free-living, lead-in, and inpatient phases of the 
study.  The increase in energy intake during the inpatient phase of the diet was designed to 
place the subjects in approximately + 15% energy balance.   
Figure 4.1 Energy intake for free-living, lead-in, and inpatient phases of the study.*Significantly 
different than free-living conditions (p<0.05). 
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Figure 4.2 Macronutrient intake for the free-living, lead-in, and inpatient phases of the study. 
*Significantly different than free-living conditions (p<0.0001 for Inpatient, p<.01 for Lead-in).     
+ Significantly different than lead-in conditions (p<0.01).  
 
Energy expenditure 
PAL and Non-exercise PAL levels did not differ between the CHO and PRO + CHO trials, 
as depicted in Figure 4.3 and Figure 4.4, respectively.  






Figure 4.4 Non-exercise PAL during inpatient CHO and PRO + CHO trials 
 
Energy balance 
During the lead-in diet, estimated mean daily positive energy balance was positive by 
15% compared to each subjects estimated maintenance caloric intake.  Subjects were in positive 
energy balance during the inpatient stay, with a mean daily positive energy balance of  + 278.1 ± 
40.70 kcal for the CHO trial, and + 313.1 ± 37.46 kcal for PRO + CHO trial as depicted in Figure 
4.5 (p=.2654). Additionally, there was no significant difference in energy balance between Days 
1-3 and Days 4-6 regardless of whether subjects were in the CHO or PRO + CHO trial as depicted 
in Figure 4.6 (p=.3127). 




Figure 4.6  Mean inpatient energy balance of Days 1-3 and Days 4-6 
 
Weight and body composition 
 Body weight did not change from pre DEXA scan (67.2±5.9 kg) to post DEXA scan 
(67.6±6.0 kg) (p=0.41).  There were no significant changes in body fat percentage (p=.23) from 
pre (33.52±3.87%) to post (32.85±3.82%) along with no significant changes is FFM (p=.24) from 
pre (45.71 ± 5.83 kg) to post (46.07 ± 5.61 kg).  The tracking of individual and group mean daily 
body weight during the inpatient period is shown in Figure 4.7.  Mean body weight did not 
change during the inpatient stay, however changes in bodyweight would have likely been 
observed over a longer duration due to positive energy balance. 




Nitrogen Balance (NBAL) 
 There was a trend for an increase in 3-day average NBAL in the PRO + CHO versus CHO 
as depicted in Figure 4.8 (p=0.0881).  The mean NBAL for the CHO trial was 0.9699 ± 0.5171 g N, 
and 1.659 ± .4296 g N in the PRO + CHO trial.  However, a calculation of the number of subjects 
needed to show a significant difference at alpha less than 0.05 at a power of 0.80 was 
determined to be 35 subjects.  If we added 2 or 4 subjects to bring our n up to 8 or 10, the 
power was determined to be 0.30 and 0.36, respectively (calculated using STPLAN V4.3, The 
University of Texas M. D. Anderson Cancer Center).  Mean NBAL data during CHO and PRO + 
CHO trial for individual subjects is presented in Figure 4.9.  Importantly all subjects were in 
positive NBAL during PRO + CHO and only one subject had a negative NBAL in the CHO trial.  
There was no significant difference in NBAL between Days 1-3 and Days 4-6 regardless of 
whether subjects were in the CHO or PRO + CHO trial as depicted in Figure 4.10 (p=0.3488).   







Figure 4.9  Mean NBAL of individual subjects and group mean during CHO and PRO + CHO trials  
 
Figure 4.10  Mean NBAL during  Days 1-3 and Days 4-6 (p=0.4775) 
 
Combined data for negative, even, and positive energy balance studies 
 By using data from all three energy status cohorts of the study (negative, even, and 
positive), further comparisons for NBAL with regards to the timing of protein intake and/or 
energy balance were made.  When combining all of the data from the negative, even, and 
positive energy balance studies, significant differences were observed for mean NBAL between 
the CHO and PRO + CHO trial (.4188 ± .2941 g N in the CHO trial, and .8505 ± .2908 g N in the 
PRO + CHO trial)(p=.01) as depicted in Figure 4.11. 
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Figure 4.11 Mean NBAL in CHO and PRO + CHO trials in all studies combined (negative, even, 
and positive energy balance) 
 
Data from all three studies was then stratified so that the 6-day mean energy balance 
percentages <0 were placed in a negative group, and 6-day mean energy balance percentages 
>0  were placed in a positive group.  Average energy balance in the adjusted model was -13.39 ± 
2.41 % for the negative group, and 12.85 ± 1.96% for the positive group (p<0.0001) as depicted 
in Figure 4.12. 
Figure 4.12 Mean energy balance in adjusted negative and positive groups (p<0.0001) 
 
  Differences in mean NBAL for the CHO and PRO + CHO trials in both the adjusted 
negative and positive energy balance groups were analyzed. There was no significant difference 
in mean NBAL between the CHO and PRO + CHO trial in the adjusted negative energy balance 
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group (p=.1782) as depicted in Figure 4.13.  However, significant differences were observed 
between the CHO and PRO + CHO trial in the adjusted positive energy balance group (.9637 ± 
.3359 g N in the CHO trial, and 1.494 ± .2555 g N in the PRO + CHO trial)(p=.0158) as also 
depicted in Figure 4.13. 
Figure 4.13 Mean NBAL in CHO and PRO + CHO trials in adjusted negative and positive energy 
balance groups (p=.1782 for Negative, p=.0158 for Positive) 
 
When  comparing the mean change in NBAL going from the CHO to the PRO + CHO trial 
in the newly adjusted negative and positive energy balance groups, the differences remained 
insignificant (p=.2435).  However, when splitting the newly adjusted negative and postive 
groups up by trial, differences in mean NBAL were significant in both the in CHO trial (p=.0085), 
and the PRO + CHO trial (p=.0016) as depicted in Figure 4.14.  Specifically, the mean NBAL values 
for the CHO trial were -0.4288 ± 0.4184 g N for the negative group, and 0.9637 ± 0.3359 g N for 
the positive group.  The mean NBAL values for the PRO + CHO trial were -.1507 ± .4728 g N for 




Figure 4.14 Mean NBAL in adjusted negative vs positive groups during CHO trial (p=.0085), and 
PRO + CHO trial (p=.0016) 
 
Energy balance and Nitrogen balance 
 A significant correlation was observed between all of the subjects daily energy balance 
and their respective daily NBAL (R2=0.065,p=.003) as depicted in Figure 4.15.  Additionally, when 
seperating the daily energy balance and NBAL by trial (CHO and PRO+CHO), no significant 
correlation was observed between daily EB and daily NBAL for the CHO trial (R2=.03450, 
p=.1265) as also depicted in Figure 4.15.  However, daily EB was significantly correlated with 
daily NBAL in the PRO + CHO trial (R2=.1149, p= 0.0044) as also depicted in Figure 4.15. 
Figure 4.15 Correlation between daily energy balance (%) and daily NBAL in Combined Trials 




Protein intake and Nitrogen balance 
 When correlating all subjects daily protein intake (g/kg bw) with daily NBAL no 
significant correlation was observed (R2=.0031, p=0.49) as depicted in Figure 4.16. However, 
once dividing the data by sex, significant correlations between daily protein intake (g/kg bw) and 
daily NBAL were observed for both females (R2=.04219, p=.0284), and males (R2=.3279, 
p=<.0001) as also depicted in Figure 4.16.  
Figure 4.16 Correlation between daily protein intake (g/kg bw) and daily NBAL for all subjects 
(p=0.49), females (p=0.0284), and males (p=<.0001) 
 
Further correlations were then made by separating both women and men into CHO and 
PRO + CHO trials.  In women, daily protein intake (g/kg bw) was not significantly correlated to 
daily NBAL in either the CHO (R2=.05099, p=.0912), or the PRO + CHO trial (R2=.03524, p=.1620). 
However, in men daily protein intake (g/kg bw) was significantly correlated to daily NBAL in both 






Figure 4.17 Correlation between daily protein intake (g/kg bw) and daily NBAL for men during 



















 The present study examined the effects of the timing of protein in relation to a bout of 
aerobic exercise on NBAL in older individuals on a hypercaloric diet.  In this study, subjects 
completed two, three-day trials that were isocaloric and isonitrogenous, where only the timing 
of a protein beverage differed with regards to a bout of aerobic exercise.  Previous research in 
our lab has examined the effects of the timing of protein intake in relation to aerobic exercise in 
older individuals in energy balance.  The original even energy balance data showed that timing 
protein intake immediately after exercise resulted in greater NBAL than if the same protein dose 
was consumed earlier in the day (Jordan, Melanson et al. 2010).  This led to the question of 
whether the timing of protein would have a similar effect when subjects were placed on a 
hypercaloric diet, since increasing caloric content increases NBAL in itself (Munro 1951; 
Butterfield and Calloway 1984).  
Contrary to data from the even energy balance study, the results of the current study 
showed that when older individuals consume protein immediately following exercise (PRO + 
CHO) on a hypercaloric diet, there was no significant increase in 3-day average NBAL than if the 
protein was consumed earlier in the day (CHO).  Although p=.0881, a calculation of the number 
of subjects needed to show a significant difference at alpha less than 0.05 at a power of 0.80 
was determined to be 35 subjects.  If we added 2 or 4 subjects to bring our “n” up to 8 or 10, the 
power was determined to be 0.30 and 0.36, respectively.   
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If the degree of positive NBAL in the positive energy balance group was maintained over 
the long-term, consuming protein immediately after exercise may lead to more significant gains 
in whole body protein than if the protein was consumed earlier in the day.  Specifically, when 
extrapolating the results of the current study over a one-month period, the CHO trial (.970 ± 
.517 g N) would result a net protein accretion of  182 g (0.970 g N·day-1 x 6.25 g PRO ·g N-1 x 30 
days), while the PRO + CHO trial (1.659 ± .430 g N) would result in a net protein accretion of 311 
g (1.659 g N·day-1 x 6.25 g PRO ·g N-1 x 30 days).  If extrapolating the 3-day mean NBAL results 
over the span of an entire year 2.2 kg of body protein would be gained in the CHO trial, with 
3.78 kg of body protein being gained in the PRO + CHO trial. These gains are theoretically 
feasible given that 1.5 kg of FFM can be accrued in women over 60 years of age during a 24 
week resistance training program (Nichols, Omizo et al. 1993).  
Our studies were unique in that they were the first studies of their kind examining the 
timing of protein intake in relation to exercise on NBAL in older individuals.  The effects of 
energy balance on NBAL have been previously elucidated.  Specifically, energy restriction results 
in a decreased NBAL (Todd, Butterfield et al. 1984; Friedlander, Braun et al. 2005), while 
increasing caloric content leads to increased NBAL (Munro 1951; Butterfield and Calloway 1984). 
However, these studies did not strictly examine an older population or the timing of protein 
with regards to exercise on NBAL.  Additionally, studies by Campbell et al., have evaluated the 
effects variable protein intakes on NBAL (Campbell and Evans 1996; Campbell WW 2001; 
Campbell, Johnson et al. 2008).  However, Campbell’s studies did not examine the timing of 
protein intake in relation to exercise on NBAL.  One study similar in design to ours was done by 
Roy et al., who examined the effects of the timing of mixed meal ingestion with regards to 
exercise on NBAL in young female athletes following two seven-day trials of increased training 
volume.  Similar to our study, the trials only differed with the timing of the mixed-meal beverage  
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(Roy, Luttmer et al. 2002).  However, the subjects in the Roy study were young female athletes, 
not older individuals at risk for wasting.  Our study did not include increased training volume, 
but used the same level of moderate intensity aerobic exercise each day which emulated the 
intensity of a brisk walk.  This is novel, since walking is the most common form of exercise in the 
elderly population (McPhillips, Pellettera et al. 1989).  Additionally, subjects in the Roy study 
were in an exercise induced negative energy balance, whereas our subjects were in positive 
energy balance.  
Data from our three studies: Negative, Even, and Positive Energy Balance 
By examining data from all three studies our lab performed, we are better able to 
understand the relationship between energy balance and timing of protein intake on NBAL.  
When combining the data from all three studies (negative, even, and positive energy balance), 
there was a significantly greater mean NBAL observed when protein and carbohydrates were 
consumed following exercise, as opposed to an isoenergetic amount of strictly carbohydrate.  
Since energy balance can change day to day in “real life” conditions, timing protein and 
carbohydrate after exercise could be considered a valid strategy at increasing NBAL in older 
individuals.   
Additionally, we decided to stratify subjects into either a negative (energy balance <0 %) 
or positive (energy balance >0 %) group.  We then were able to examine differences in mean 
NBAL between the CHO and PRO + CHO trial in both the adjusted negative and positive energy 
balance groups.  
No significant differences in mean NBAL were observed between trials in the adjusted 
negative energy balance group.  The lack of significant differences (p=.1782) in NBAL between 
trials in the adjusted negative group somewhat contradict previous findings by Roy and 
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colleagues who found that consuming a mixed meal beverage immediately following exercise 
resulted in a strong trend (p=.06), albeit insignificant, towards a more positive NBAL than if 
consuming the same beverage earlier in the day while in an exercise induced negative energy 
balance state (Roy, Luttmer et al. 2002).  Although subjects in the Roy study consumed their 
habitual energy intake, calories from exercise were not replaced which led to subjects being in 
negative energy balance, as evidence by weight loss in both trials.  Although impossible to 
pinpoint, the differences between our findings and Roy’s may be attributed to a potentially 
smaller caloric deficit achieved by subjects in the Roy study, as energy balance was not directly 
determined in the Roy study.  
Contrary to subjects in negative energy balance, significant differences in mean NBAL 
were observed between trials in the adjusted positive energy balance group.  Therefore our data 
indicates that timing protein intake after exercise has a greater impact on improving NBAL when 
in positive energy balance than when in negative energy balance.   
 When comparing these newly formed positive and negative groups, we found that 
significant differences existed in mean NBAL in both the CHO and PRO + CHO trials of each 
study.  However, the difference in mean NBAL between negative and positive energy balance 
groups was more pronounced in the PRO + CHO trial than the CHO trial.  Although significant 
differences in mean NBAL existed between energy balance groups for the CHO trial, these 
differences may likely be attributed to the impact of energy balance alone, since increasing 
energy intake increases NBAL in itself (Munro 1951; Butterfield and Calloway 1984).  Since 
greater differences in mean NBAL were observed between energy balance groups for the PRO + 
CHO trial than the CHO trial, timing protein intake after exercise appears to have an additional 
benefit in increasing NBAL above increasing energy balance alone.   
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The issue of energy balance is often ignored in studies examining protein turnover.  
Specifically, due to the short term nature measurements of protein turnover using tracer 
methods, whole day energy balance is often ignored.  Since “real life” scenarios involve multiple 
periods of fasting and feeding throughout the day, the issue of whole day energy balance cannot 
be ignored.  By using the NBAL method, we were able to evaluate the effects of the timing of 
protein intake with regards to exercise on whole body protein turnover over the span of an 
entire day.   Our findings indicated that in combination with timing protein intake after exercise, 
maintaining a positive energy balance will yield greater increases in NBAL than timing protein 
intake after exercise while in negative energy balance.  Together, this data suggests that energy 
balance is likely more important than the timing of protein intake with regards to NBAL in older 
individuals. 
NBAL has been shown to acutely increase but diminish over time when subjects are 
subjected to exercise and overfeeding, indicating NBAL adaptation (Butterfield and Calloway 
1984).  However, the adjusted positive model shows that consuming protein immediately after 
exercise (PRO +CHO) is still more beneficial at increasing NBAL than consuming the same protein 
beverage earlier in the day (CHO trial).  Therefore, by consuming a hypercaloric diet combined 
with protein consumption immediately following moderate aerobic exercise, older adults may 
be able to reduce the losses in LBM associated with aging.  However, prolonged exposure to a 
hypercaloric diet is not recommended due to the negative health consequences associated with 
weight gain.  Rather, older individuals in negative energy balance would benefit from increasing 
caloric intake and timing protein intake after exercise in order to increase NBAL. 
Our studies were the first of their kind to evaluate the combined effects of variable 
energy balance states and the timing of protein intake with regards exercise on NBAL in an older 
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population. When in negative energy balance, timing protein and carbohydrates (PRO + CHO) 
after exercise led to no significant increases in NBAL than if consumed earlier in the day. The 
lack of significant differences in NBAL while in negative energy balance may be attributed to the 
fact that, regardless of timing, more amino acids are being oxidized for energy with less being 
available for the synthesis of new proteins.  Conversely, when in positive energy balance, timing 
protein and carbohydrates (PRO + CHO) after exercise led to significant increases in NBAL more 
so than if consumed earlier in the day.  Since increased caloric intake spares amino acid 
oxidation, more amino acids are available for the synthesis of new proteins. Specifically, the 
amino acids consumed after an exercise stimulus are likely utilized for anabolic processes since 
they are not required for energy production. 
Energy Balance and Nitrogen Balance  
Significant correlations were observed with daily energy balance and daily NBAL when 
both CHO and PRO + CHO trials were combined.  However, when seperating by trial, the 
correlation between relative energy balance and NBAL was only significant in the PRO + CHO 
trial.  Therefore, it appears that energy balance may be more determinant of NBAL when 
protein and carbohydrates are consumed immediately following exercise, rather than an 
isoenergetic amount of strictly carbohydrates.   Our findings demonstrated that in a hypercaloric 
state, consuming protein and carbhoydrates after exercise resulted in a greater NBAL than if 
consumed before exercise.  By consuming protein and carbohydrates after exercise, amino acids 
are likely utilized for anabolic processes rather than being oxidized for energy.  
Protein intake and Nitrogen Balance 
No significant correlations were observed with subjects’ daily protein intake (g/kg bw) 
and daily NBAL.  However, once seperating subjects by sex we found significant correlations for 
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protein intake (g/kg bw) and NBAL in both women and men.  This data indicates that relative 
protein intake is predictive of NBAL in men and women when seperated by sex.  Once we 
further divided the sex based groups up by CHO and PRO + CHO trial we found a strong 
correlation between daily protein intake (g/kg bw) and daily NBAL in men only (R2=.2515, 
p=.0205 for CHO,R2=.4346, p=.0012 for PRO + CHO).  Therefore, in older men, relative protein 
intake is more predictive of NBAL when protein and carbohydrates are consumed immediately 
following aerobic exercise, rather than an isoenergetic amount of strictly carbohydrates.  To our 
knowledge this is the first evidence showing any type of sex related differences regarding 
relative protein intake and protein timing, on NBAL.  It’s possible that since the men had a 
greater average exercise workload, that they better utilized the amino acids for synthetic 
purposes after exercise.  Additionaly, the more anabolic endocrine profile of men may allow 
them to use more of the ingested amino acids for synthetic processes than women.  Sex 
differences with regards to protein intake’s contributive effects on NBAL should be further 
explored. 
NBAL method 
 Since the NBAL method used in our three studies does not elucidate rates of protein 
synthesis, or protein breakdown, we are unable to determine with certainty how net protein 
balance amongst all of the studies was achieved.  However, there is evidence that MPB actually 
decreases with age (Morais, Gougeon et al. 1997), which would indicate that changes in NBAL 
may be partially attributed partially to changes in MPS.  In addition, it is impossible to be certain 
where protein is being deposited using the NBAL technique.   By design, our studies employed 
the NBAL technique since we were concerned with WBPT in the elderly.  Worth noting is that 
prior research has shown that skeletal muscle contribute just under 30% of the WBPT rate (Nair 
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1995).  Therefore, increases in NBAL are likely correlated with increases in skeletal muscle, 
however overall increases in whole body protein was the primary concern of our study.  
Maintaining and/or increasing whole body N retention is extremely important during 
the aging process.  As mentioned previously, outside of skeletal muscle, 25% of protein is found 
in body organs, and approximately 35% found in the skin and blood (Gropper 2009). Therefore, 
it is intuitive that decreases in whole body protein would have adverse effects on overall health 
and wellbeing.   
Limitations 
The NBAL technique may overestimate NBAL values (Kopple 1987).  Specifically, N intake 
can be overestimated if food is not completely consumed, which would result in a higher 
calculated NBAL.  However, subjects were instructed to consume all foods given to them, with 
meal consumption closely monitored during the inpatient period to ensure that all foods and 
beverages were ingested.  Additionally, N intake is estimated based on total protein intake, with 
6.25 grams of protein containing approximately 1 gram of N.  However, the idea that 6.25 grams 
of protein contains 1 g of N is an average based on protein quality.  Additionally, inadequate 
collection of any excreted N can also contribute to the overestimation NBAL.  Directly calculating 
miscellaneous N losses can be quite challenging, and therefore relies on estimates.  Therefore, 
there is some possibility that NBAL was overestimated.  However, any measurement errors 
would occur during both conditions to the same extent.  Therefore, the difference in observed 
NBAL between trials would remain constant despite the possibility to overestimate NBAL. 
Despite the limitations to the NBAL technique, it is easy to employ and provides 
information regarding the WBPT.  The noninvasive nature of the NBAL method makes it a useful 
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technique for studying protein turnover in the aging population.  Additionally the NBAL method 
allows researchers to study WBPT over an extended period of time.  
During the even energy balance study, an extra 160 calories (in the form of CHO) was 
provided during the inpatient diets.  These extra calories were due to an error in the nutritional 
information for the Kool-Aid beverage, which means that the post-exercise beverages in the 
even energy balance study were not isocaloric.  However, since the protein synthetic  effect of 
carbohydrate is dependent on the amount ingested, the NBAL values in the CHO condition were 
likely more positive than they would have been if the Kool-Aid was isocaloric with the chocolate 
milk.   
Protein and exercise recommendations for older adults  
There have been a multitude of exercise and nutritional interventions studied with 
regards to their impact on attenuating wasting.  Our studies examined the combined effects of 
exercise and the timing of protein on NBAL under variable energy balance states.  Our combined 
data shows that consuming protein after exercise results in greater NBAL than if consumed 
earlier in the day while in positive energy balance.  By timing the milk intake after exercise, 
NBAL likely increased due to the combined effects of protein and carbohydrate at increasing 
MPS following exercise (Howarth, Moreau et al. 2009).  Since more amino acids are utilized for 
synthetic processes, fewer amino acids are oxidized or excreted.  Therefore, milk consumption 
immediately following moderate intensity aerobic exercise provides a possible method for 
attenuating sarcopenia by increasing NBAL. 
However, our data also suggests that energy balance is more important than the timing 
of protein intake with regards to improving NBAL.  Therefore, older individuals should focus on 
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consuming adequate calories first and foremost with the timing of protein intake a secondary 
concern. 
Additionally, although increasing protein intake has shown mixed results at increasing 
NBAL (Gersovitz, Motil et al. 1982; Castaneda, Charnley et al. 1995; Campbell WW 2001), 
research has shown that meals with at least 25-30g protein/meal (~10g EAA) maximally 
stimulate protein synthesis (Paddon-Jones D 2009).  Although our study diets were not based 
around this idea, older individuals may be further able to increase postprandial protein 
synthesis and attenuate wasting by consuming 25-30 g protein/meal.  
Future directions 
In the future, a longer term intervention examining milk intake after exercise with 
regards to NBAL should be explored.  Although likely difficult to administer, a longitudinal cohort 
could evaluate whether consuming milk after exercise could prevent wasting in subjects starting 
the intervention around ages 45-50 years before symptoms typically surface.  
Additionally, longer-term research evaluating sex related differences in the correlation 
between relative protein intake and whole body protein balance should be explored.  These 
studies should also examine age related sex differences in NBAL and relative protein intake. 
Other research in our lab has shown that post exercise protein supplementation does 
not increase MPS over the course of 6 weeks (Robinson, Turner et al. 2011).  Thus, it may be 
possible that the timing of protein intake does not make a difference in long-term MPS. 
However, to our knowledge, long-term NBAL studies examining the timing of protein intake 
have not been carried out.  By examining the timing of protein intake on long-term NBAL, we 
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may be able to elucidate if protein timing has differential effects on protein kinetics at the whole 
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Consent Form Approval              
Date:       Valid For Use Through:___________ 
 
SUBJECT CONSENT FORM 
 
COLORADO MULTIPLE INSTITUTIONAL REVIEW BOARD 
Protocol #08-0640 
 
And CSU IRB 
Protocol # 08-187H 
 
“Consumption of milk after physical activity - rethinking protein recommendations in older 
individuals” 
 
PRINCIPAL INVESTIGATOR: Edward L. Melanson, Ph. D. and Benjamin F Miller, PhD 
 
Version #1 
Last Updated: June 12, 2008 
 
 
You are being asked to be in a research study.  This form provides you with information about 
the study. A member of the research team will describe this study to you and answer all of your 
questions. Please read the information below and ask questions about anything you don’t 
understand before deciding whether or not to take part.  
 
Why is this study being done? 
This study plans to learn more about how to prevent muscles from wasting with the aging 
process.  We would like to use a simple strategy using exercise and 
nutrition.  What this study seeks to determine is when you have protein can be just as important 
as how much protein you receive.  In the two study periods what you eat will be the same, but 
when you eat it will be different.  
You are being asked to be in this research study because you are a healthy individual aged 55-
75.   
Other people in this study 
Up to 40 people from your area will participate in the study.  
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What happens if I join this study? 
If you join the study, you will first complete a physical screening including a screening for heart 
disease at Colorado State University. We will ask you to answer some questions about your past 
and current participation in exercise.  Your body weight, height, and body composition will be 
measured by laying in a bed and being scanned.  Your gender and date of birth will also be 
recorded.  A 3 tsp sample of blood will be taken for screening purposes.  Before undergoing the 
sampling procedures, you will be asked a few questions relating to your present state of health, 
current medication and past medical history.  This is to exclude the presence of any condition or 
medication that might prolong your bleeding time or make the blood sampling unsafe for you.  
This visit will take approximately 30 minutes. 
You will also undergo cardiac screening in the presence of a cardiologist.  This will involve the 
placement of ten collecting electrodes on your chest that will be connected to an 
electrocardiogram (ECG).  You will then be asked to walk on a treadmill, slowly at first and 
progressively faster until the cardiologist asks you to stop.  This test will take approximately 45 
minutes.  If anything adverse is found in any of the medical screening, you will be advised.   
In the seven-day period leading up to the study, we will provide you with all of your food from 
the Department of Food Science and Human Nutrition at CSU.  The food will be normal food 
tailored to your diet, but we ask that you only consume this food.   
For the study, you will report to the general clinical research center (GCRC) at the Colorado 
Health Sciences Center the night before the start of the study and sleep over night.  You will 
then remain in the GCRC for six days.  During this stay you will be asked to exercise once per day 
for one hour on a bike.  The exerciseintensity will be slightly more than that required to 
complete a brisk walk.  During the entire stay you will also be fed a controlled diet that will be 
slightly more (approximately 200 kcal) than your normal calorie and protein intake and you will 
wear a monitor to measure the amount of activity.  You will receive a protein supplement either 
in the morning or after your exercise bout and when you receive the protein supplement will 
switch half way through the stay. Throughout the study all your urine will be collected for 
analysis. In addition, we will collect a small blood sample (2 tsp) at three different times.  For a 
24 hr period at the beginning of the study and at the end of the study, you will reside in a room 
that will measure the rate your body is using energy.  This room contains everything you will 
need for normal living, but is specially designed for our measurements.  After you exit the 
special room on the last day, you will receive one more body scan for body composition.  
In total your commitment to the study is a half-day for screening, seven days with normal living 
and food provision, and a six-day (seven-night) stay at the GCRC.   
What are the possible discomforts or risks? 
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In this study we will need to get a total of about 9 teaspoons of blood from you. We will get 
blood by putting a needle into one of your veins and letting the blood flow into a glass tube.  
You may feel some pain when the needle goes into your vein.  A day or two later, you may have 
a small bruise where the needle went under the skin.   If you have not participated in a regular 
exercise program before, you may experience some discomfort with the exercise bout including 
muscle soreness or labored breathing.  You may experience discomfort (boredom) associated 
with a prolonged stay in our facility and special room.  However, all efforts will be made to 
ensure your comfort including access to television, internet, and daily exercise.   
Other possible risks include a small risk (less than 1 in 10 000) of death due to a cardiac event 
during exercise screening.   There are also risks of fatigue and muscle strains.  You may 
experience temporary breathlessness or dizziness towards the end of the test.  These feelings 
are transient and pass once the test is finished.  During your daily exercise there is also a risk of 
cardiac complications but in individuals with good cardiac health this risk is extremely low (1 in 1 
000 000).   
As part of this study we will perform two DEXA scans of your body.  DEXA is a way of looking 
inside the body by using X-rays.  X-rays are a type of radiation.  Your natural environment has 
some radiation in it.  This DEXA will give you about the same amount of radiation that you would 
get from your environment in four days.   
This study may include risks that are unknown at this time 
What are the possible benefits of the study? 
This study is designed for the researcher to learn more about potential non-pharmaceutical 
treatments for the prevention of muscle wasting with aging.  We want to incorporate easy-to-
follow strategies for improved muscular health.  You will receive a medical and cardiac screen 
and will obtain information on your body composition.  
This study is not designed to treat any illness or to improve your health.  Also, there may be 
risks, as discussed in the section describing the discomforts or risks. 
Who is paying for this study?  
This research is being funded by the Colorado Agricultural Experiment Station with the mission 
of increasing the quality of foods in Colorado.   
Will I be paid for being in the study?   
You will not be paid for the screening tests or travel expenditures, but you will be paid $300 for 
completion of the GCRC stay.  If you leave the study early, or if we have to take you out of the 
study, you will be paid $40 for each overnight stay. 
It is important to know that payments for participation in a study are taxable income.  
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Will I have to pay for anything? 
It will not cost you anything to be in the study. 
Is my participation voluntary? 
Taking part in this study is voluntary.  You have the right to choose not to take part in this study.  
If you choose to take part, you have the right to stop at any time.  If you refuse or decide to 
withdraw later, you will not lose any benefits or rights to which you are entitled.  
Can I be removed from this study?  
The study nurse, Rebecca Benson PA/RN, or her supervising physician, Robert Eckel, MD, may 
decide to stop your participation without your permission if the  
study nurse/doctor thinks that being in the study may cause you harm, or for any other reason.  
What happens if I am injured or hurt during the study? 
You should inform your care provider(s) if you decide to participate in this research study. If you 
have questions about injury related to the research, you may call the study coordinator, Edward 
Melanson, Ph.D. at (303) 724-0935 and/or your private physician. Edward Melanson, Ph.D. 
should be informed about any injury you experience while you take part in this study.  If you are 
hurt by this research, we will give you medical care of you want it, but you will have to pay for 
the care that is needed. 
Who do I call if I have questions? 
The researchers carrying out this study are Dr. Ed Melanson and Dr. Benjamin Miller. You may 
ask any questions you have now. If you have questions later, you may call Dr. Melanson at 303-
724-0935 or Dr. Miller at 970-491-3291. You will be given a copy of this form to keep.   
 
You may have questions about your rights as someone in this study. You can call Dr. Melanson 
at 303-724-0935 or Dr. Miller at 970-491-3291 with questions.  You can also call the Colorado 
Multiple Institutional Review Board (COMIRB).  You can call them at 303-724-1055.  
 
The main person to talk to if you have questions about this study is Dr. Melanson at 303-724-
0935 or Dr. Miller at 970-491-3291.  You can also talk to a Subject Advocate at the General 
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Clinical Research Center (GCRC)/ the Clinical Translation Research Center (CTRC).  The phone 
number there is720-848-6662.  
Who will see my research information? 
We will do our best to keep your research records private. But there are some people and 
agencies who will be allowed to see them.  These include:  
 
• Federal offices such as the Food and Drug Administration (FDA) that protect research 
subjects like you. 
• People at the Colorado Multiple Institutional Review Board (COMIRB) 
• The study doctor and his/her team of researchers. 
• Officials at Colorado State University or the Colorado Health Sciences Center who are in 
charge of making sure that we follow all of the rules for research 
 
We might talk about this research study at meetings.  We might also print the results of this 
research study in relevant journals.  But we will always keep the names of the research subjects, 
like you, private.   
 
We will ask you to sign a different form that talks about who can see your research records.  
That form is called a HIPAA form.  It will mention companies and universities who will see your 
research records.  
 
You have the right to request access to your personal health information from the Investigator. 
[To ensure proper evaluation of test results, your access to these study results may not be 
allowed until after the study has been completed – if applicable]. 
 
This HIPAA authorization does not expire.  However, you may withdraw this authorization for 
use and disclosure of your personal health information by providing written request to the 
Investigator. If you withdraw this authorization, the Institution, the Investigator, the research 
staff, and the research Sponsor will no longer be able to use or disclose your personal health 
information from this study, except so far as that they have already relied on this information to 
conduct the study. 
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Agreement to be in this study 
I have read this paper about the study or it was read to me.  I understand the possible risks and 
benefits of this study.  I know that being in this study is voluntary.  I choose to be in this study: I 
will get a copy of this consent form. 
Signature:         Date: _____ 
 
Print Name:         
 
Consent form explained by:                  Date:   
 
Print Name:         
 







































Authorization To Use or Release 
Health Information About Me 
For Research Purposes 
Authorization B: Enrollment into Research 
 
Study Title: Consumption of milk after physical 
activity - rethinking protein recommendations 
in older individuals 
 
 
COMIRB Number: 08-0460 
 
I (Subject’s Full 
Name) authorize 
 
  (PI or Physician Name) and 
staff members of 
 
 (Facility Name) working for him/her to use the 
following health information about me for research:(Please check the appropriate boxes.  
NOTE:  If a category is checked “yes” and a line follows the category, you MUST describe the type 
of the procedures done.) 
 
No Yes 
 Name and/or phone number   
 Demographic information (age, sex, ethnicity, address, etc.) 
 Diagnosis(es) 
 History and/or Physical 
 Laboratory or Tissue Studies:   
 Radiology Studies:   
 Testing for or Infection with Human Immunodeficiency Virus (HIV) (or results)   
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 Procedure results:    
 Psychological tests:   
 Survey/Questionnaire:   
 Research Visit records 
 Portions of previous Medical Records that are relevant to this study 
 Billing or financial information 
 Drug Abuse  
 Alcoholism or Alcohol abuse  
 Sickle Cell Anemia  
 Other (Specify):   
For the Specific Purpose of 
 Collecting data for this research project 
 Other*   





If my health information that identifies me is also going to be given out to others outside the 
facility, the recipients are described on the next page(s). 




The PI (or staff acting on behalf of the PI) will also make the following health information 
about me available to:  (check all that apply and describe the type of the procedures done 
where applicable)  
Recipient   (name of person or group)  
 
No Yes 
All Research Data Collected in this Study (if you check this box Yes, no other boxes need to 
be checked in this section) 
All Research Data Collected in this Study except for name, phone number, and/or address 
(if you check this box Yes, no other boxes need to be checked in this section) 
 
 
  Name and phone number   
  Demographic information (age, sex, ethnicity, address, etc.) 
  Diagnosis(es) 
  History and Physical 
  Laboratory or Tissue Studies:   
  Radiology Studies:   
 Testing for or Infection with Human Immunodeficiency Virus (HIV) (or results)  
 Procedure results:   
  Psychological tests:   
  Questionnaire/Survey:   
  Research Visit records 
  Portions of previous Medical Records that are relevant to this study 
  Billing/Charges  
 Drug Abuse  
 Alcoholism or Alcohol  
 Sickle Cell Anemia  




For the Specific Purpose of 
 Evaluation of this research project 
 Evaluation of laboratory/tissue samples 
 Data management 
 Data analysis 
 Other*:   
*Cannot say “for any and all research”, “for any purpose”, etc. 
For additional Recipients, copy this page as needed. 
I give my authorization knowing that: 
1. I do not have to sign this authorization.  But if I do not sign it the researcher has the right to 
not let me be in the research study.   
2. I can cancel this authorization any time.   
1. I have to cancel it in writing.   
2. If I cancel it, the researchers and the people the information was given to will still be 
able to use it because I had given them my permission, but they won’t get any more 
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information about me.   
3. If I cancel my authorization, I may no longer be able to be in the study. 
4. I can read the Notice of Privacy Practices at the facility where the research is being 
conducted to find out how to cancel my authorization. 
5. The records given out to other people may be given out by them and might no longer be 
protected.  
6. I will be given a copy of this form after I have signed and dated it.   
 
This authorization will expire on:  (Date) OR 
  The end of the research study 
  Will not expire 
  
      (Describe dates or circumstances under which the authorization will expire.) 
 
 






Subject’s Signature       Date 
  
Signature of Legal Representative (If applicable)               Date 
  
Name of Legal Representative (please print 
  





Site: Colorado State University, Dr. Benjamin Miller 
 
I give my authorization knowing that: 
7. I do not have to sign this authorization.  But if I do not sign it the researcher has the right to 
not let me be in the research study.   
8. I can cancel this authorization any time.   
9. I have to cancel it in writing.   
10. If I cancel it, the researchers and the people the information was given to will still be 
able to use it because I had given them my permission, but they won’t get any more 
information about me.   
11. If I cancel my authorization, I may no longer be able to be in the study. 
12. I can read the Notice of Privacy Practices at the facility where the research is being 
conducted to find out how to cancel my authorization. 
13. The records given out to other people may be given out by them and might no longer be 
protected.  
14. I will be given a copy of this form after I have signed and dated it.   
 
This authorization will expire on:  (Date) OR 
  The end of the research study 
  Will not expire 
  
      (Describe dates or circumstances under which the authorization will expire.) 
 
 









Signature of Legal Representative (If applicable)                            Date 
  
Name of Legal Representative (please print) 
  












































DEPARTMENT OF HEALTH AND EXERCISE SCIENCE 
 




NAME__________________________       GENDER___________  DATE______________ 
 







1. How often do you exercise?  ______________ times/week 
 
2. Describe the intensity of your exercise (circle one) 
 1 = none 
 2 = light (e.g. casual walking, golf) 
 3 = moderate (e.g. brisk walking, jogging, cycling, swimming) 
 4 = heavy (e.g. running, high intensity sport activity) 
 
3. What types of exercise do you engage in and how much do you do each session? (circle all that apply) 
 1 = none 
 2 = walking ________ km or minutes 
 3 = jogging/running __________  km or minutes 
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 4 = swimming ___________ meters or minutes 
 5 = cycling ____________  km or minutes 
 6 = team sports (rugby, cricket, soccer, etc.) __________minutes __________ intensity 
 7 = racquet sports ___________minutes 
 8 = weight training ___________minutes __________# reps ___________# sets 
 9 = other ________________________________________________________________ 
 
4. How much time per week do you spend exercising?  ___________ hours/week 
 
5. Do you measure your heart rate during exercise?  ___________ 
 If yes:   
 a. How high does it get during your typical workout?  __________ beats/min 
 b. What heart rate is maintained throughout most of your workout?   __________beats/min 
 
6. How long have you had a regular exercise program?_________ 
 
 
7. What condition or shape do you consider yourself to be in now (in terms of physical fitness)? 
 1 = poor 
 2 = fair 
 3 = good 
 4 = excellent 
 
8. Do you or have you ever smoked?  _________ 
 If yes:  How long ago?_________  For how many years?_________  How many packs/day?________ 
 







10. Has a close blood relative had or died from heart disease or related disorders (Heart Attack, Stroke,  
 High Blood Pressure, Diabetes etc.)? 
 1=Mother 
 2=Father 
 3=Brother - Sister 
 4=Aunt - Uncle 
 5=Grandmother - Grandfather 
 6=None 









 If yes- write the date and value (or if it was normal or abnormal) 
 ____________________________________________________________________________________ 
 
12. Indicate which of the following apply to you (circle all that apply). 
 1 = high blood pressure 
 2 = high blood fats or cholesterol 
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 3 = cigarette smoking 
 4 = known heart disease or abnormalities 
 5 = family history of heart disease (parents or siblings before age 50) 
 6 = sedentary lifestyle 
 7 = stressful lifestyle at home or at work 
 8 = diabetes mellitus 
 9 = gout (high uric acid) 
            10 = obesity 
 
13. Any medical complaints now (illness, injury, limitations)? 
 1 = yes               If yes, describe completely__________________________________________ 
 2 = no                 _______________________________________________________________ 
                                    _______________________________________________________________ 
 
14. Any major illness in the past? 
 1 = yes               If yes, describe completely__________________________________________ 
 2 = no                 _______________________________________________________________ 
                                    _______________________________________________________________ 
                                    _______________________________________________________________ 
 
15. Any surgery or hospitalization in the past? 
 1 = yes               If yes, describe completely__________________________________________ 
 2 = no                 ______________________________________________________________ 
                                    ______________________________________________________________ 
                                    ______________________________________________________________ 
 
16. Are you currently taking any medications (prescription or over-the-counter: including birth control)? 
108 
 
 1 = yes               If yes, list drugs and dosages _________________________________________ 
 2 = no                 _______________________________________________________________ 
                                    _______________________________________________________________ 
                                    _______________________________________________________________ 
 
17. Are you allergic to any medications? 
 1 = yes               If yes, list medications_____________________________________________ 
 2 = no                ________________________________________________________________ 
                                   ________________________________________________________________ 
                                   ________________________________________________________________ 
 
 
18. Have you ever had any neurological problems? 
 1 = yes                If yes, describe completely__________________________________________ 
 2 = no                  _______________________________________________________________ 
                                     _______________________________________________________________ 
 
19. Do you now have, or have you ever had, any of the following? (circle all that apply) 
 1 = heart murmurs 
 2 = any chest pain at rest 
 3 = any chest pain upon exertion 
 4 = pain in left arm, jaw, neck 
 5 = any palpitations 
 6 = fainting or dizziness 
 7 = daily coughing 
 8 = difficulty breathing at rest or during exercise 









20. Do you now have, or have you ever had, any of the following? (circle all that apply) 
 1 = any bone or joint injuries 
 2 = any muscular injuries 
 3 = muscle or joint pain following exercise 
 4 = limited flexibility 
 5 = any musculoskeletal problems which might limit your ability to exercise 
 
 Please describe fully any items you circled___________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
 
